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1 INTRODUCTION  
1.1 Sperm production and maturation 
The male reproductive system consists of the testes, epididymis, accessory glands, penis, 
and the excretory ducts [1]. The main function of the testis is spermatogenesis and androgen 
(e.g. testosterone) production [2]. Spermatogenesis occurs inside the seminiferous tubules 
where successive mitotic and meiotic divisions of primordial germ cells (spermatogonia) and 
their derivatives generate haploid spermatids which are subsequently differentiated to 
spermatozoa (Figure 1) [3]. Necessary growth factors and nutrients for successful 
spermatogenesis are provided by the Sertoli cells [2]. After meiosis, gene transcription and 
translation in haploid germ cells is reduced before it completely ceases in elongating 
spermatids [4]. In the rete testis, spermatozoa are collected from the lumen of the 
seminiferous epithelium and then transferred to the epididymis [5, 6]. 
  
 
 
Figure 1. Spermatogenesis occurs in the testis. (A, B) Spermatozoa are generated inside the 
seminiferous tubules of the testis. (C, D) Primary spermatocytes, which are generated from diploid 
spermatogonia by mitosis, produce haploid sperm following two meiotic divisions. (E) Global gene 
transcription is substantially decreased during spermatogenesis, and finally stopped after production in 
                                                                                                                        INTRODUCTION 
 
2 
 
the testis and during epididymal maturation of spermatozoa [7]. (© 2015 The Authors. Molecular 
Reproduction and Development published by Wiley Periodicals, Inc) 
  
The testis is connected to the vas deferens through the epididymis. Caput, corpus, and 
cauda constitute the three regions of the epididymis [8]. Connective tissue septa divide the 
epididymis into 10 separate segments in both human and mouse [8-10]. The epididymis is 
lined by epithelial cells which are encompassed by smooth muscle cells and interstitial tissue 
stroma [8, 11]. Furthermore, immune cells (e.g. lymphocytes and macrophages) are present 
intraepithelialy and in the interstitium [11]. Spermatozoa acquire their fertilization potential 
during passage through the epididymis by interaction with epithelial cell secretions [12]. The 
maturation of spermatozoa further proceeds with the aid of accessory gland (such as the 
seminal vesicles, prostate gland, and bulbourethral glands) secretions [13]. 
1.2 Capacitation and acrosome reaction 
Since spermatozoa encounter different stimuli (e.g. oestrogen, progesterone) during transit 
through the female reproductive tract and follicle cell layers (such as cumulus oophorus), 
membranes of sperm head undergo profound biochemical and physiological alterations. These 
gradual procedures of sperm modifications are defined as capacitation [14]. Glycoconjugates 
mainly locate on the cell surface, and they are also entitled as the glycocalyx [15]. The sperm 
glycocalyx is vulnerable to the different pH in the female genital tract [14] and sugar moieties 
of the sperm glycocalyx (e.g. sialic acids) can be removed or remodeled during capacitation 
[16]. Capacitation is considered as a prerequisite for activation of the acrosome reaction. In 
the female reproductive tract massive changes in the lipid content and the composition of the 
sperm membrane prepare for a successful acrosome reaction. Such lipid alterations (i.e. in the 
ratio of cholesterol to phospholipids) not only disrupt membrane stability, but also increase its 
permeability [14]. 
Moreover, progesterone and prostaglandins trigger the acrosome reaction via calcium 
fluxes. The influx of calcium takes place as one of the initiating events in the acrosome 
reaction [17]. High concentration of calcium in sperm impacts on transportation of other ions 
such as K+, Na+, and H+. Accordingly, the osmotic pressure of sperm head changes, resulting 
in enlargement of the acrosome followed by exocytosis. Activation of protein kinases and G-
coupled receptors conduct underlying mechanisms for induction of the acrosome reaction 
[14]. 
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Released enzymes from the acrosome are crucial for facilitating the forward movement of 
sperm towards the oocyte through the multiple layers of the granulosa cells [14]. Additionally, 
transferred signals from the zona pellucida promote the acrosome reaction [18].  
1.3 Epididymitis  
Infectious epididymitis or epididymo-orchitis in men, a frequent entity in urological 
outpatient settings, is commonly caused by bacteria ascending the genitourinary tract [19]. 
The majority of patients suffering uropathogenic Escherichia coli (UPEC)-caused 
epididymitis are over 35 years [20]. UPEC are the major pathogen associated with 
epididymitis [21, 22]. Apart from UPEC, other types of pathogens are also involved in 
epididymitis such as Pseudomonas aeruginosa (in acute patients older than 35 years) as well 
as Neisseria gonorrhoeae and Chlamydia trachomatis (in patients younger than 35 years) [22, 
23]. Causative bacteria in epididymitis are mainly transmitted sexually. Since these pathogens 
invade in a retrograde fashion by ascending from the urethra into the epididymis, epididymal 
inflammations are usually associated with urine infections. Moreover, the risk of UPEC 
infection in homosexual men is elevated [19]. 
1.3.1 Symptoms and damage in epididymitis patients  
 Semen analysis showed that spermatogenesis is impaired in 60% of epididymitis patients 
[21]. Sperm concentrations and the number of germ cells decreased in these patients [20, 24] 
and a substantial amount of sperm abnormalities (i.e. azoospermia and oligozoospermia) was 
reported in the ejaculate of these patients. Furthermore, membrane integrity decreased in 
infected sperm [25]. Hence, epididymitis patients suffer permanently or transiently from 
infertility problems. In clinical diagnosis, swelling of the epididymis, especially in the cauda 
region of these patients, is commonly observed using sonographic examinations [26, 27]. 
Other symptoms of epididymitis include pain, hydrocele, and sepsis. In a large numbers of 
epididymitis patients the testis is co-infected (termed epididymo-orchitis) [26]. 
 According to the recommendations of European Association of Urology (EAU), 
antibiotic therapies may eradicate pathogens within around two weeks [20]. Furthermore, 
antimicrobial regimes improve semen parameters leading to a rise in the number of normal 
and a reduction in abnormal forms of spermatozoa. Antibiotics are prescribed up to 84 days in 
some resistant cases, nevertheless, these E. coli pathovars either still persist or cause relapse 
of infections. Moreover, Lang et al. claimed that in spite of antibiotic regime, sperm 
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concentration of UPEC infected men remains substantially lower than men infected with 
commensal E. coli [24]. Taken together, it is estimated that in 40% of acute epididymitis 
patients impairment of fertility persists [20]. 
1.3.2  Experimental murine model of UPEC-induced epididymitis  
This mouse epididymitis model is a useful model to unravel the mechanism how UPEC 
impairs the normal tissue structures in the host genito-urinary tract. Lang et al. displayed 
severe clinical manifestations (e.g. swelling, redness, edema) in infected mice comparable to 
common symptoms in UPEC epididymitis patients. 3 days post UPEC infection bacteria are 
mainly found the lumen of the epididymis. Moreover, epithelial cells in the epididymis are 
damaged and devoid of stereocilia. Infection strongly perturbs the integrity of surrounding 
layers of the cauda (e.g. smooth muscle cells and tight junctions). Concomitant to tissue 
damage immune cells infiltrate the epididymis postinfection (Figure 2). On the endocrine 
level, serum testosterone concentrations are substantially diminished in the infected mice. 
Interestingly, acrosome analysis of sperm in in vivo UPEC treated mice revealed that 
spermatozoa substantially lose their acrosomes [24].  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                        INTRODUCTION 
 
5 
 
Figure 2. Histopathological alterations following UPEC infection in the cauda epididymis of 
the experimental model. Masson-Goldner staining of the epididymis sections 3 days after PBS 
treatment (sham control) and UPEC infection demonstrates that a massive fibrotic remodeling 
(represented by arrows) i.e. thickening of the smooth muscle cell layer, and collagen accumulation 
together with interstitial infiltrating leukocytes (indicated by circles) occurs only in the cauda 
epididymis compared with the caput which remains largely intact [28]. (Copyright © 2016, by the 
American Society for Biochemistry and Molecular Biology) 
 
Consistent with Lang et al., using the same model Stammler et al. demonstrated that the 
epididymis segments located in the distal cauda manifested severe defects in histology of 
epithelial cells and muscle cells [8]. However, as a possible protective mechanism upon the 
ascending of UPEC, contraction may occur in the epididymal duct. As a result, UPEC ascend 
is slowed down to move upward from the cauda segments to other regions [8].  
1.4 Uropathogenic Escherichia coli 
UPEC differ from non-pathogenic E. coli strains, which also colonize the urinary tract as 
commensal flora, since UPEC encode genes involved in tissue invasion [29]. UPEC are 
known to be implicated in 60% of male genito-urinary tract infections [30]. Ascend of these 
gram-negative opportunistic pathovars to the bladder and kidneys results in cystitis and 
pyelonephritis, respectively [21]. Furthermore, genito-urinary tract infections are associated 
with male infertility in up to 10-15% of infertile cases [30]. 
UPEC modulate inflammatory immune reactions [31, 32]. Controversial studies claim that 
cytokine production followed by UPEC infection is either elevated in mouse in vivo 
epididymitis model [33, 34] or conversely attenuated in testicular cells and epithelial cells in 
the bladder [35-37]. Furthermore, neutrophils infiltrate post UPEC infection [21].  
As a defense mechanism to eliminate UPEC, antibacterial products such as reactive 
oxygen species (ROS) are enhanced by leukocytes. Elevated amounts of ROS impair fertility 
through negative effects on concentration and motility of spermatozoa as well as the ROS-
mediated damage of sperm nuclear deoxyribonucleic acid (nDNA) [38, 39]. However, low 
levels of ROS enhance sperm normal physiological activities e.g. motility, exocytosis of the 
acrosome, and interactions with the oocyte [40, 41]. 
1.4.1 UPEC virulence factors 
UPEC employ a variety of virulence factors such as adhesins and alpha-hemolysin (hlyA). 
Adhesins (also termed pili), including P and type 1 fimbria, mediate initial attachments to host 
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cells [21, 29]. FimH as a member of type 1 fimbria plays an adhesive and invasive role in 
urinary tract infection via specific binding of the FimH pocket to epithelial cell receptors 
employing high mannose structures [42]. Moreover, FimH is essential in the formation of 
biofilm-like structures in bladder intracellular. UPEC evade innate immunity and antibacterial 
therapies using biofilm structures [43]. 
 UPEC secret hlyA to enhance attachment and colonization of UPEC within the genito-
urinary tract [21, 29]. HlyA is a virulence factor and is expressed in at least half of UPEC 
isolates. Moreover, hlyA as a causative agent is particularly found in acute epididymitis 
patients [21, 44]. Toxicity of hlyA arises from calcium affinity as well as the formation of 
pores in the membranes [88, 92-94]. HlyA belongs to the repeat-in-toxin family which 
contains a binding domain to calcium ions [45]. High levels of hlyA generate pores that 
trigger cell lysis [21]. HlyA establishes infection via modulations of cell survival and 
signaling pathways [46]. In vitro treatment of sperm with hlyA showed that hlyA impairs 
fertility via premature induction of the acrosome reaction. In addition, hlyA treated sperm lose 
the potential of in vitro fertilization and formation of blastocyst [24]. 
Together with these virulence factors, many other agents like capsule K, mannose-
resistant adhesins, and the aerobactin system are also involved in the dissemination of UPEC 
infections [44]. 
1.5 Glycans 
Glycans are defined as arrays of monosaccharides which are covalently linked together 
with glycosidic bounds (Figure 3). There are different abbreviation systems to demonstrate 
glycan compositions (Figure 3) [15].  
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Figure 3. Nomenclature symbols and abbreviations of monosaccharides and glycan structures. 
(A) Common symbols which are used for demonstrating of monosaccharide moieties. (B) In order to 
exhibit glycan structures, several systems (such as full, modified, and symbolic representations) are 
applied [15]. (Permission from Cold Spring Harbor Laboratory Press)  
 
Glycans can conjugate with lipids and proteins through covalent bonds to form 
glycolipids and glycoproteins [15]. In eukaryotic cells, predominant forms of glycoconjugates 
consist of proteoglycans, glycosphingolipids, and glycoproteins (Figure 4) [47]. 
Glycoproteins occur in three classes, i.e. O-glycans, N-glycans, and O-GlcNAc glycoproteins. 
In addition to glycoproteins, other types of glycosylated structures exist in living organisms. 
For instance, in lipid conjugated forms, polysaccharide chains are bound either to ceramide 
(termed glycosphingolipids) or phosphatidylinositol (defined as glycolipids) which are 
attached to proteins (together termed glycosylphosphatidylinositol (GPI)). Moreover, 
hyaluronan is a free form of glycosaminoglycans (GAG). GAGs can also be associated with 
conjugated forms of proteoglycans (e.g. heparan sulfate, dermatan sulfate, and chondroitin 
sulfate) (Figure 4) [15, 47].  
The mass of glycoconjugates is largely comprised of the glycan part. The high number of 
glycosylated structures compared to the total number of genes in living organisms implies that 
glycan biosynthesis is not directly template based (from genome to protein), but is a product 
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of posttranslational modifications. Among many types of monosaccharides in nature only 
limited types are expressed in animals. The major types of monosaccharides in animal 
glycostructures are pentoses, hexoses, deoxyhexoses, hexosamines, uronic acids, and sialic 
acids. Furthermore, two possible anomeric forms of monosaccharide attachments (α or β) 
elevate the complexity of glycan structures. The diversity of sugars is further expanded with 
modifications e.g. acetylation, methylation, phosphorylation, and sulfation in hydroxyl and 
amino groups. Carbohydrate structures in large extent form the architecture of cells, tissues, 
and organs. The majority of glycans are secreted or occur on the cell surface. They contribute 
actively to a variety of related physiological functions such as cell-cell interactions, 
development, cell signaling, and host-pathogen interactions [15]. Glycans are also essential 
for fertility through induction of the sperm acrosome reaction and interactions of sperm with 
the zona pellucida [48, 49].  
 
 
Figure 4. Different types of glycoconjugate structures in eukaryotic cells. N-glycans (a), O-
glycans (b), and O-GlcNAc glycoproteins (g) are three classes of glycoproteins which differ in 
initiating amino acids and monosaccharides in the attachment site. Glycoconjugated lipids (e.g. 
glycosphingolipids (c) and glycosylphosphatidylinositol (GPI) (d)) and proteoglycans (f) (e.g. heparan 
sulfate, dermatan sulfate, and chondroitin sulfate) are other common glycoconjugates in living 
organisms. In addition to proteoglycans, polysaccharide forms of GAGs are freely found in the 
                                                                                                                        INTRODUCTION 
 
9 
 
structure of hyaluronan (e) in the extracellular matrix [15, 47]. (License number of permission: 
4145370715258) 
 
1.5.1 Glycoproteins 
The classification of glycoproteins into N- and O-glycans, as two main classes of 
glycoproteins, is based on the type of amino acids in binding sites including asparagine (Asn) 
in N-glycans, and serine (Ser) or threonine (Thr) in O-glycans (Figure 4). However, some 
similar sequences, e.g. N-acetyllactosamine disaccharide (Galactose (Gal) β1-4 N-
acetylglucosamine (GlcNAc) β1), are present in both N- and O-glycans. These sequences are 
either terminated with fucose (Fuc) or sialic acid, or further extended by the addition of 
polysialic acid (polySia) chains [15]. The third class of glycoproteins is O-GlcNAc, 
containing N-acetylglucosamine (GlcNAc) which is bound to Ser/Thr in proteins. O-GlcNAcs 
are located in the cytoplasm and the nucleus (Figure 4) [15, 47]. 
Microheterogeneity of glycoproteins in individual cells mainly arises from variations in 
the binding sites of glycans to peptides together with differences in the compositions of 
attached glycans. Therefore, cell-specific microheterogeneity substantially enhances the 
variations of glycoproteins [15].  
Nucleotides transporting monosaccharides such as uridine diphosphate (UDP)-sugar and 
guanosine diphosphate (GDP)-sugar are precursors of glycans. Nucleotide-monosaccharides 
are synthesized in the cytosol or the nucleus. These sugar donors are actively transferred to 
the endoplasmic reticulum (ER) and the Golgi apparatus which are responsible organelles in 
the biosynthesis of structural and secreted glycoproteins [50]. Biosynthesis of glycans by 
means of glycosyltransferases originates primarily in the ER and in the Golgi complex [51, 
52]. Secreted glycoproteins are transferred intracellularly or released within vesicles and 
lysosomes [53]. In addition to structural differences between N- and O-glycans, their 
biosynthesis and functions are various [14]. 
Glycans are enzymatically degraded by endoglycosidases and exoglycosidases. Final 
degradation of glycans occurs in the lysosomes. Cleaved monosaccharides are exported to the 
cytosol. Therefore, glycans are dynamically recycled in the cells [53].   
Evolutionary knowledge of glycans is not well understood. As-yet-known, the 
composition of glycans is varied both intraspecies and interspecies. Furthermore, recently 
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evolved species of animals carry more complex compositions of N- and O-glycan. Expression 
of unusual structures and modification of glycostructures lead to specific physiological 
functions which play important roles in competitions pertaining to the evolutionary selection 
pressures, e.g. in host-pathogen interactions [54]. 
1.5.1.1 N-glycans  
In N-glycans, attachments of sugar chains to peptides initiate with the binding of GlcNAc 
to Asn in a consensus sequence of Asn-X-Ser/Thr. N-glycans are categorized into three 
classes: high mannose, hybrid, and complex (Figure 5). Nevertheless, a common core 
structure of five monosaccharides, which consists of 2 GlcNAc and 3 mannose (Man), 
contributes to all types of N-glycans [15].  
Biosynthesis of N-glycans initiates at the cytoplasmic face of the ER. A lipid-like 
structure (termed dolichol phosphate (Dol-P)) is the precursor of N-glycans. GlcNAc-P is 
transferred from UDP-GlcNAc to Dol-P. Subsequently, thirteen extra sugars are combined 
sequentially to Dol-P to generate the N-glycan precursor. During the synthesis of the 14-
monosaccharides precursor, an anchored Dol-P (including Glc3Man9GlcNAc2) is translocated 
to the lumen face of the ER membrane, where the oligosaccharide precursor is subsequently 
bound to Asn. Furthermore, temporary oligomannose structures undergo a required 
processing in order to reach final form of N-glycans using series of glycosidases and 
glycosidase transferases in the ER and the Golgi complex [55]. 
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Figure 5. Three major structures of N-glycans. The majority of N-glycans have a common 
pentasaccharide core sequence, i.e. 2 GlcNAc and 3 Man (red dashed line box). Differences in the type 
and structure of sugar residues in branches result in classification of N-glycans into oligomannose, 
complex, and hybrid types [56]. (Permission from Cold Spring Harbor Laboratory Press) 
 
N-glycan mutant murine models cause lethal defects at the embryonic development stage, 
e.g. deletion in N-acetylglucosaminyltransferase I (GlcNAcT-I or Mannosyl (Alpha-1,3-)-
glycoprotein beta-1,2-N-acetylglucosaminyltransferase (Mgat 1)) as the initiating enzyme in 
the synthesis of complex-type N-glycans in the Golgi [57, 58]. In addition, the impairment of 
N-glycan biosynthesis attributes to genetic diseases, e.g. congenital disorders of glycosylation 
[59]. Taken together, severe consequences, which are associated with defects in N-linked 
structures in both mouse and human, underpin the physiological importance of N-glycans [57-
59].  
1.5.1.2 O-glycans  
The most common type of O-glycans is so called mucin-type since they are mainly found 
in mucins. Mucins are high molecular weight glycoproteins, containing numerous O-glycans. 
Biosynthesis of mucin-type O-glycans is initiated by the attachment of N-acetylgalactosamine 
(GalNAc) to the hydroxyl group of Ser or Thr (Figure 4). Binding of GalNAc to the 
corresponding amino acid is catalyzed by a GalNAc transferase (GalNAcT). More than 20 
types of GalNAcT exist in the Golgi apparatus. GalNAcTs contribute to the synthesis of a 
variety of mucins in a tissue- and/or cell-specific manner. In contrast to N-glycans, the 
biosynthesis of O-glycans is simpler, and the structure is less branched. However, O-glycans 
contain long chains with terminal variations. Mucins are massively detectable in the surface 
membranes and secretions of many epithelial cells (e.g. in the genitourinary tract), mediating 
antimicrobial function as a physical and chemical barrier to infection [60]. Other 
monosaccharides are successively added to initially bound GalNAc in different ways, making 
up to 8 types of core structures (Table 1) [61].  
Table 1. Extension pattern of mucin O-glycans. O-glycans that are initiated by binding of 
GalNac to Ser/Thr are enlarged by different monosaccharides and linkage types [60]. (Permission 
from Cold Spring Harbor Laboratory Press) 
 
O-glycan cores Structure 
Tn antigen GalNAcαSer/Thr 
Sialyl-Tn antigen Siaα2-6GalNAcαSer/Thr 
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Core 1 or T antigen Galβ1-3GalNAcαSer/Thr 
Core 2 GlcNAcβ1-6(Galβ1-3)GalNAcαSer/Thr 
Core 3 GlcNAcβ1-3GalNAcαSer/Thr 
Core 4 GlcNAcβ1-6(GlcNAcβ1-3)GalNAcαSer/Thr 
Core 5 GalNAcα1-3GalNAcαSer/Thr 
Core 6 GlcNAcβ1-6GalNAcαSer/Thr 
Core 7 GalNAcα1-6GalNAcαSer/Thr 
Core 8 Galα1-3GalNAcαSer/Thr 
 
In addition to O-GalNAC structures, O-fucose and O-glucose modifications of glycans, 
which are identified as the non-mucin types of O-glycans, are mainly found in epidermal 
growth factor-like repeats and play a critical role in Notch signaling and embryonic 
development. O-fucosyltransferases (POFUT), which occur in 2 variants (POFUT1 and 2), 
and O-glucosyltransferase (POGLUT) initiate the generation of O-fucose and O-glucose 
glycan structures, respectively. Fuc residues in the structure of epidermal growth factor 
contribute to Notch signaling [61, 62]. Some studies claimed that Notch signaling is essential 
for normal spermatogenesis and Leydig cell function [63, 64]. By contrast, Batista et al. 
revealed that Notch signaling only takes place in Sertoli cells. Furthermore, deletion of 
Notch1 does not disturb spermatogenesis and fertility competence [65].   
O-mannose glycans are another type of O-glycans that are highly present in the brain, and 
play an active role in the adhesion of neuronal cells [61]. Furthermore, O-mannose 
compositions contribute to the linkage of the extracellular matrix and cytoskeleton through 
occurrence in dystroglycan structures [66]. There are two responsible enzymes for priming the 
synthesis of O-mannose structures termed O-mannosyltransferase 1 and 2 (POMT1 and 2) 
[61].   
1.6  Role of glycans in fertilization 
Carbohydrate parts of the zona pellucida (e.g. O-glycans in ZP3) are involved in induction 
of the acrosome reaction [67, 68]. Subsequently, the cumulus cells and zona pellucida 
glycocalyx are substantially modulated following the acrosome reaction. The cumulus cells 
and zona pellucida are surrounded by GAG layers, containing a disaccharide sequence of 
GlcNAc repeats called hyaluronan [69-71]. Hyaluronidases (e.g. PH20 in pigs) are situated in 
the sperm acrosome and are activated after release by the acrosome reaction. Hyaluronidases 
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specifically digest the hyaluronan layer of the egg, resulting in the penetration of sperm 
through the extracellular matrix of the oocyte in the cumulus [72]. Besides hyaluronidases, β-
N-acetylglucosaminidases are released from sperm after the acrosome reaction and cleave 
outermost GlcNac moieties that are excessively present in hyaluronan structures. Whereas 
inhibition of β-N-acetylglucosaminidase suppresses fertilization, this enzyme seems to be 
crucial for sperm passing through surrounding layers of the zona pellucida [73].  
1.7 Sialic acids 
Sialic acid residues occur mostly at the outermost position of eukaryotic glycoconjugates 
on the cell surface and glycosylated secretions [74, 75]. However, sialic acids may also bind 
to internal positions of glycans. In addition to the extensive presence in higher invertebrates 
and vertebrates, sialic acids are also found in bacteria, which are either pathogens or belong to 
commensal flora [76].  
1.7.1 Sialic acid structure 
Sialic acids are a α-keto acids family of nine-carbon backbone amino monosaccharides 
and include more than 50 members. In mammals, N-acetylneuraminic acid (Neu5Ac) and N-
glycolylneuraminic acid (Neu5Gc) represent the most abundant species among sialic acid 
members (Figure 6) [77, 78]. During evolution, humans have irreversibly lost the biosynthesis 
potential for Neu5Gc due to a genetic mutation in Cytidine monophosphate (CMP)-N-
acetylneuraminic acid hydroxylase [79, 80]. Unlike other monosaccharides, the nucleotide-
sugar precursor of sialic acid is CMP-Sia [50]. Synthesis of sialic acids in eukaryotes occurs 
in the Golgi apparatus. Moreover, sialyl-transferases mediate attachment of sialic acids to 
glycan structures. Sialic acids from a position of C-2 are able to bind into C-3 or C-6 of 
underlying monosaccharide moieties (i.e. Gal or GalNac)  [81]. 
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Figure 6. Sialic acid localization and structure. Sialic acids mostly occupy the terminal part of 
glycostructures (highlighted in red boxes). Neu5Ac and Neu5Gc are two most prevalent types of the 
sialic acid superfamily in mammals, which differ structurally in one extra oxygen atom bound to C-5 
of Neu5Gc (represented in blue)[82]. (License number of permission: 4145330580662) 
 
1.7.2 Physiological and pathological roles of sialic acids  
 The occurrence of millions of sialic acid moieties, carrying negatively charged 
carboxylate groups to the largest share of glycoproteins, remarkably elevates the 
hydrophobicity of the cell surface. As a result, cell-cell interactions are regulated [83, 84]. For 
instance, sialic acids raise repulsion of cells (e.g. blood cells) to avoid undesired cell 
interactions [85]. Taken together, electrostatic features and outermost localization enable 
sialic acids to mediate a wide variety of important biological roles, ranging from immune 
response to development and many other essential activities, as described in many studies 
[74-78, 86]. 
In normal conditions, sialic acids contribute to receptor-ligand interactions. This is the 
case for Factor H as well as sialic acid-binding immunoglobulin-type lectins (Siglecs), which 
implicate numerous immunomodulatory functions [85]. In addition, sialic acids play various 
roles during an ongoing infection [76]. The presence of sialic acid in receptors of several 
pathogens facilitates the binding of bacteria or viruses to host cell [77, 87-89]. For instance, 
their binding sites (e.g. Helicobacter pylori, influenza virus A, and influenza virus C) together 
with toxins from some pathogens (e.g. Plasmodium falciparum, Vibrio cholerae), all share 
specific type and linkage of sialic acids [85]. Given sialic acids contribute to the suppression 
of immune response, some pathogens cover their surface with sialic acids to mislead immune 
defense [90]. This mimicry approach of pathogens for surviving in hosts is acquired by two 
main mechanisms. On one hand, several pathogens (such as Escherichia coli K1, Neisseria 
meningitides B, Group B Streptococcus) are able to generate de novo sialic acid [90]. On the 
other hand, some other pathogens steal sialic acids from host either directly (e.g. Hemophilus 
influenzae) or indirectly with the aid of trans-sialidase and sialyltransferase (e.g. 
Trypanosoma cruzi and Neisseria gonorrhoeae, respectively) (Figure 7) [90].  
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Figure 7. Sialic acids contribution to a variety of physiological and pathological functions. In 
biological processes, sialic acids widely contribute to binding of intrinsic receptors. Nevertheless, 
sialic acids mediate roles in pathogenicity since sialic acids can also be recognized by some pathogens 
as extrinsic receptors. In addition, some pathogens exploit host sialic acids to evade immune response 
via a mimicry mechanism [85]. (License number of permission: 4140931321525) 
 
1.7.3 Role of sialylated glycans in fertilization 
The zona pellucida family are extracellular matrix glycoproteins (i.e. ZP 1-4 in human) 
that cover the surface of the vertebrate oocytes [91, 92]. Fertilization initiates with the binding 
of sperm to the zona pellucida. Oligosaccharide parts of the zona pellucida were widely 
identified in contact sites with sperm receptors [18]. Unlike N-glycans, O-linked glycans of 
ZP3 play an essential role in the primary attachment of gametes [67, 93]. Moreover, the 
presence of Gal residues, particularly in O-glycans, is known to be necessary for zona 
pellucida-sperm interaction [91]. However, mass spectrometry (MS) analysis of the zona 
pellucida binding sites to human sperm demonstrated the high presence of sialylated capped 
tetrasaccharide sequences termed Sialyl-Lewisx (SLex). The SLex oligosaccharide consists of 
NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAc and occurs in the zona pellucida inside bi-, tri-, and 
tetra-antennary structures of both N- and O-glycans (Figure 8) [49].  
Biological roles 
 of sialic acids 
Roles of sialic 
acids in 
pathogenicity 
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Figure 8. Sperm-zona pellucida attachment is mediated by surface sialic acids. Terminal 
sialic acids (represented in red circles) in an oligosaccharide array of Sialyl-Lewisx (SLex) in 
combination with Gal (green triangles), GlcNAc (blue diamonds), and Fuc (yellow boxes) exist in the 
primary interaction site of sperm-zona pellucida [94]. (Reprinted with permission from AAAS)  
 
In addition to its contribution to the zona pellucida, SLex mediates a similar adhesion role 
during metastasis of cancer cells. Moreover, SLex is known to have a role in the accumulation 
of blood cells (such as platelets or leukocyte) during proinflammatory response [95, 96]. 
Nevertheless, the concentration of SLex in the zona pellucida is approximately double 
compared with somatic cells [49]. Furthermore, Pang et al. observed the lower rate of 
fertilization after blocking of SLex sequence either using antibodies against sialylated motifs 
or by applying synthetic sialylated glycoconjugates. In contrast to the SLex oligosaccharide, 
Lewisx sequence, which is devoid of the terminal sialic acid, failed to manifest any inhibitory 
effect on the rate of sperm-zona pellucida binding. Thus, these studies indicate that sialic 
acids in the SLex sequences on the extracellular surface of the egg serve as responsible ligands 
for sperm attachment [49].  
1.8 Sperm glycocalyx  
Thick layers of glycans capped with millions of sialic acid moieties encompass the sperm 
surface. Several classes of glycoconjugates such as glycolipids, glycoproteins (both N- and O-
glycans), GAGs (e.g. chondroitin and heparan sulfate), and GPI-anchored glycoproteins (e.g. 
CD52) decorate the sperm surface (Figure 9) [7, 97, 98].  
 SLex 
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Figure 9. Distribution of different classes of glycostructures on the sperm surface. Glycan 
structures are mainly conjugated to proteins and lipids (represented in gray). Furthermore, other 
glycoconjugates are associated with glycosphingolipids and cholesterol (represented in orange and 
yellow, respectively). Further modifications such as acetylation and/or sulfation may also occur in 
sperm glycoconjugates [7]. (© 2015 The Authors. Molecular Reproduction and Development 
published by Wiley Periodicals, Inc)  
 
In comparison to glycoprotein layers of the zona pellucida surrounding the female gamete, 
the size of the sperm glycocalyx is remarkably thinner (20 to 60 µm in sperm versus 1 to 16 
nm in the zona pellucida). On the other hand, more than 50 different glycoconjugates are 
present in the sperm glycocalyx, while only 3 or 4 glycoproteins constitute the zona pellucida 
(ZP 1-4). Hence, glycoprotein diversity and surface heterogeneity of glycoconjugate 
structures in sperm are indeed more complex than the homogeneous structure of the zona 
pellucida [98].  
1.8.1 Biosynthesis of sperm glycoconjugates 
The sperm glycocalyx is primarily generated de novo during spermatogenesis in the 
seminiferous tubules using several sets of glycosyltransferases. Biosynthesis of the sperm 
glycocalyx takes place co- and post-translationally in the ER and Golgi (Figure 10) [7]. In the 
epididymis, sperm spontaneously is unable to de novo biosynthesis of glycans; nevertheless, 
epididymal maturation mediates a decisive role in the alteration of sperm glycoconjugates [7]. 
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Spermatozoa glycostructures undergo substantial modifications during transmit from the 
epididymis, where they come in contact with epididymal glycosyltransferases and 
glycosidases secreted in the lumen [99-102]. Some glycostructures on the sperm surface are 
only restricted to one specific region of the epididymis (i.e. caput, corpus, or cauda), 
indicating that glycoconjugates are selectively incorporated into and/or removed from sperm 
in a region-specific manner [101, 102]. Similarly, the epididymis functions actively in 
production and incorporation of sialic acids into the sperm membrane during sperm 
maturation and ejaculation [99]. 
 
 
 
Figure 10. Biosynthesis and alterations of sperm glycoconjugates. ER and Golgi apparatus are 
the responsible organelles in initiation and elongation of sperm glycoconjugates. Subsequently, 
generated glycoconjugates are either secreted or translocated onto the surface of sperm membranes. 
Some alterations in the sperm glycocalyx occur in epididymal lumen due to interaction with 
glycosidases and glycosyltransferases, e.g. fucosyltransferase (FUCT), galactosyltransferase (GALT), 
and sialyltransferase (SIAT). Glycoconjugates are abbreviated as follows: GnT1IP (GlcNAcT‐I 
inhibitory protein), GdS (glycodelin S), GALNT3 (N-acetylgalactosaminyltransferase 3), MUC 
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(mucin), DEFB126 (ß-defensin 126), αMII (alpha‐mannosidase II), Mx (alpha‐mannosidase IIx), 
GALGT1 (N‐acetylneuraminyl‐galactosylglucosylceramide N‐acetylgalactosaminyltransferase), 
SULFF (heparin sulfate 6‐O endosulfatase), and SIAT (sialyltransferase) [7]. (© 2015 The Authors. 
Molecular Reproduction and Development published by Wiley Periodicals, Inc) 
 
1.8.2 Conventional methods to analysis sperm glycocalyx 
Classical sugar studies on the sperm glycocalyx are mainly dependent on lectin 
applications [103, 104]. Additionally, glycoproteomics analysis of sperm glycans using MS 
applications revealed the presence of several glycan compositions associated with sperm 
[105]. 
1.8.2.1 Lectin analysis of sperm carbohydrates 
Lectins are carbohydrate-binding proteins with a strong affinity to specific sugar moieties 
in a lock-and-key manner [106, 107]. Since the majority of lectin studies have been performed 
on ejaculate samples, the outcome of sperm glycocalyx analysis is biased towards sperm 
isolation and preparation procedures. For example, different fixation methods affect the 
outcome of the acrosome staining [108]. Moreover, as a general disadvantage of lectin 
staining, it is known that various technical conditions and parameters such as alteration in 
lectin concentration as well as time and temperature of incubation per se may substantially 
influence the quality of results [109, 110]. However, some lectins, for instance, Concanavalin 
A (Con-A), are able to specifically detect the sperm acrosome in the testis and post-testicular 
regions. Additionally, since Con-A recognizes the acrosome in a variety of species, it may 
imply that the binding epitope of Con-A on the sperm acrosome serves as a conserved epitope 
across various species [111]. Wheat germ agglutinin (WGA) lectin binds to sialylated 
disaccharides, including sialic acid and GlcNac [98]. Intriguingly, based on a lectin profiling 
study, WGA is able to recognize all different parts of sperm (i.e. acrosome, equatorial 
segment, post-acrosomal region, midpiece, and tail) with a pronounced fluorescence signal 
[103]. In addition to Con-A and WGA, other lectins with an exclusive affinity to various 
monosaccharides (such as Peanut agglutinin (PNA), Gal; Soya bean agglutinin (SBA), 
GalNac; Pisum sativum agglutinin (PSA), Man; Ricinus communis agglutinin (RCA), 
GalNac; and Lens Culinaris agglutinin (LCA), Man) are able to detect specific regions of 
sperm [103, 104]. Furthermore, analyzing the pattern of sperm sugars using WGA showed 
that sperm sialic acids are elevated during epididymal passage [98].  
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Exclusive affinity of Fuc-specific lectins (e.g. Ulex europaeus agglutinin 1 (UEA-1), 
Tetragonobolus (TPA), Anguilla anguilla agglutinin (AAA) and Lotus tetragonolobus (LTL)) 
to the acrosome, but not to plasma membrane, represents the differences in glycan 
compositions between the acrosome and the sperm membrane [49, 112]. In addition, these 
fucolectins specifically recognize Lewisx trisaccharide (i.e. α-L-Fuc-(1-3)-[β-D-Gal-(1-4)]-D-
GlcNAc) and Lewisy tetrasaccharide (i.e. α-Fuc-(1-2)-β-Gal-(1-4)-(α-Fuc-[1-3])-GlcNAc) 
motifs (Figure 10), proposing the associations of Lewisx and Lewisy sequences with the sperm 
acrosome [105]. 
1.8.2.2  Glycoproteomics analysis of sperm glycans 
Pang et al. in a Matrix-assisted laser desorption/ionization (MALDI)-MS profiling study 
represented a variety of possible N-glycans on sperm. These identified structures belong to 
two classes of N-linked glycoproteins: a) the high mannose (also named as oligomannose) 
structures which carry between 5 to 9 Man, and b) the complex structures which include 
several types of branched compositions such as bisected bi-antennary, bi-, tri-, and tetra-
antennary on sperm. Furthermore, this study demonstrated the association of Fuc moieties in 
both reducing ends of glycans and antennae of complex N-glycans in the composition of 
Lewisx and Lewisy sequences (Figure 11) [105].  
 
 
Figure 11. Predominant classes of N-glycans associated with sperm. MALDI-MS analysis of 
human sperm displayed that spermatozoa comprise two major classes of N-glycans such as (A) high 
mannose as well as different complex structures, including (B) bisected bi-antennary structure and (C) 
bi-, tri-, and tetra-antennary structures which may be capped with Fuc moieties in Lewisx and/or 
Lewisy sequences [105]. (Copyright © 2007, by the American Society for Biochemistry and Molecular 
Biology) 
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1.8.3 Functional roles of sperm glycans in the female reproductive tract  
The epididymis secretes and incorporates CD52 and ß-defensin 126 (DEFB126) into the 
sperm surface [7]. CD52 is a member of GPI-anchored proteins and carries both N- and O-
glycans, which share highly sialylated N-acetyllactosamine repeats [7]. These epididymis- 
mediated modifications in the sperm glycocalyx play essential roles in acquiring the 
fertilization competence [99-102]. DEFB126, which is a heavily sialylated O-glycan 
terminated with sialic acids in both α2,3 and α2,6 linkage forms, is one of the well-
characterized glycoproteins associated with sperm [7, 113]. During epididymal maturation, 
DEFB126 is secreted and incorporated into the sperm surface when sperm passes through the 
distal corpus and cauda regions (Figures 9 and 10) [114, 115]. Importantly, DEFB126 plays 
essential roles in the protection of sperm against pathogens as well as in sperm penetration 
through cervical mucus towards the oocyte and subsequent sperm-zona pellucida attachments 
[115, 116]. 
PolySia chains (containing α2,8 sialic acid polymers) are attached to N-linked 
glycoproteins. PolySia is highly expressed and functions during differentiation of stem cells 
and at the time of neuronal and skeletal muscle development. Moreover, polySia regulates 
immunity [117, 118]. In human sperm, polySia is located in the postacrosomal region and 
equatorial ring. In addition, Simon et al. claimed that polySia molecules suppress neutrophil 
extracellular traps (NET). By this virtue, polySia actively contributes to sperm survival upon 
female immune response [119].  
Lewis sequences in glycan structures mediate immunoregulatory effects [105]. For 
instance, Glycodelin S (GdS) weakly binds to sperm, but occurs abundantly in seminal 
plasma. GdS is a non-sialylated N-glycan that bears Lewisx and Lewisy sequences [7]. 
Together with its immunosuppressive role, GdS protect sperm from untimely capacitation 
[120]. 
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1.9 Aim of the study 
A previous study of the group using the murine experimental acute epididymitis model 
demonstrated premature acrosome reaction as well as drastic structural changes in the 
spermatozoa and the epididymis, including a significant reduction in sperm concentration, 
epithelial damage and fibrotic changes, at day 3 post UPEC infection [24]. During invasion 
several pathogens use cell surface sialic acids for adhesion to host cells [85, 90]. These 
findings together with Ma et al., which revealed a massive release of sialic acids in a mimicry 
capacitation condition [16], prompted us to investigate the possible changes in the presence 
and content of sialylated glycans after UPEC infection in mouse and human spermatozoa. We 
hypothesize that UPEC or their secreted virulence factors may impair male reproductive 
potential by putative modifications of the sperm glycocalyx.  
To do so, we will analyze the cellular sialylation status of sperm sialic acids in both 
human patients with a history of acute epididymitis and our well-established mouse 
epididymitis model compared to healthy controls. Additionally, we aim to investigate the 
effects of UPEC on the sialic acid levels of epididymal epithelial cells. To this end, we will 
measure the sialome status of epithelial cells in the cauda region of the mouse model. In 
agreement with sialic acid quantitative analysis, the morphological status of the acrosomes 
after infection will be figured out. Along with sialic acid analyses, N-glycan compositions of 
human sperm will be separately analyzed using LC-MALDI-MS/MS approach. Consequently, 
we plan to investigate possible alterations in N-glycans following the acrosome reaction.  
Taken together, the current study aims to survey whether alterations in sialic acid moieties 
take place in the sperm glycocalyx as a consequence of UPEC epididymitis. Additionally, we 
try to collect evidence for introducing the sperm glycocalyx as a diagnostic marker of UPEC 
induced infertility. Finally, this study may imply some salvaging mechanisms for surviving 
sperm during infection that may be promising for therapeutic intervention in male infertility 
caused by UPEC epididymitis.  
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2 MATERIALS AND METHODS 
2.1 Materials
2.1.1 Chemicals                                
Acetic acid Merck, Darmstadt, Germany   
Acetonitrile 
Acetone 
Th. GEYER, Renningen, Germany          
Merck, Darmstadt, Germany   
2-aminobenzaminde (2-AB) Sigma, Taufkirchen, Germany 
Ammonium Bicarbonate Sigma, Steinheim, Germany  
Ammonium formate Sigma, Taufkirchen, Germany 
Bactoagar Sigma, Steinheim, Germany  
Bactotryptophan Sigma, Steinheim, Germany  
Bouin’s solution Sigma, Steinheim, Germany 
Bovine serum albumin (BSA) Roth, Karlsruhe, Germany 
Bromophenol blue sodium salt  Sigma, Steinheim, Germany  
Calcium ionophore A23187 Sigma, Taufkirchen, Germany 
Dichloromethane Promochem, Wesel, Germany  
2,5-dihydrobenzoic acid (DHB) Sigma, Taufkirchen, Germany 
Dimethyl sulfoxide (DMSO) Sigma, Taufkirchen, Germany 
Dulbecco´s PBS (1X)    PAA, Cölbe, Germany 
Eosin Roth, Karlsruhe, Germany 
Ethanol Fluka Analytical, Hamburg, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
Ethylene diaminetetraacetic acid disodium (EDTA)  Merck, Darmstadt, Germany 
Formaldehyde solution 37% Roth, Karlsruhe, Germany  
Formic acid Sigma, Steinheim, Germany  
Glycerol Merck, Darmstadt, Germany 
Human tubal fluid (HTF) medium  Irvine Scientific, Santa Ana, USA 
Hydrochloric acid (HCl)  Sigma, Steinheim, Germany  
Isopropanol (2-propanol) Sigma, Steinheim, Germany  
2-keto-3-deoxynononic acid (KDN) Sigma, Taufkirchen, Germany 
Mayer’s hematoxylin Merck, Darmstadt, Germany   
β-mercaptoethanol Sigma, Steinheim, Germany  
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Methanol Merck, Darmstadt, Germany   
Methyl iodide Merck, Darmstadt, Germany   
4,5-methylenedioxybenzene (DMB) Dojindo, Kumamoto, Japan 
N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid 
(DANA) 
Sigma, Taufkirchen, Germany 
N-acetylneuraminic (Neu5Ac) Sigma, Taufkirchen, Germany 
N-glycolylneuraminic (Neu5Gc) Sigma, Taufkirchen, Germany 
Peptide Calibration Standard Bruker Daltonics, Bremen, Germany 
Phenylmethylsulfonyl fluoride (PMSF)    Thermo Scientific, Waltham, USA 
PureLink® RNA Mini Kit  Life Technologies, Carlsbad, USA 
RPMI 1640 Invitrogen, Darmstadt, Germany 
Sodium acetate Sigma, Steinheim, Germany 
Sodium borohydride (NaBH4) Sigma, Taufkirchen, Germany 
Sodium cyanoborohydride (NaBH3CN) Sigma, Steinheim, Germany  
Sodium hydrosulfite Sigma, Taufkirchen, Germany 
Sodium hydroxide (NaOH) Sigma, Steinheim, Germany  
TOPRO®-3  Life Technologies, Carlsbad, USA 
Trifluoroacetic acid (TFA) Promochem, Wesel, Germany  
Tris-acetate  Roth, Karlsruhe, Germany 
VECTASHIELD® mounting medium Vector Laboratories, Burlingame, USA 
 
 
2.1.2 Enzymes 
Neuraminidase Vibrio Cholerae Roche, Mannheim, Germany 
N-glycosidase F (PNGase F)   Roche, Mannheim, Germany 
Trypsin Sigma, Steinheim, Germany 
 
2.1.3 Lectins 
Maackia amurensis agglutinin (MAA)                                       Vector Laboratories, Burlingame, USA 
Peanut agglutinin (PNA)                                            Vector Laboratories, Burlingame, USA 
Pisum sativum (PSA)                                                 Vector Laboratories, Burlingame, USA 
Sambucus Nigra (SNA)                                            Vector Laboratories, Burlingame, USA 
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2.1.4 PCR reagents 
Deoxyribonuclease (DNase) Life Technologies, Carlsbad, USA  
Desoxyribonukleosidtriphosphate (dNTP)  Promega, Mannheim, Germany 
Moloney Murine Leukemia Virus (M-MLV) 
Reverse Transcriptase  
Promega, Mannheim, Germany 
Oligo dT  Promega, Mannheim, Germany 
Primers Life Technologies, Carlsbad, USA  
RNase inhibitor (RNAsin®)  Promega, Mannheim, Germany 
Taq polymerase  Promega, Mannheim, Germany 
 
2.1.5 Equipment 
Adhesive Caps  Zeiss, Munich, Germany 
Amide column  TOSOH Bioscience, Tokyo, Japan 
Autosampler (Midas)  Spark, Emmen, Netherland 
Bead homogenizer (TissueLyser) Qiagen, Hilden, Germany 
Blood agar plates  Oxoid, Wesel, Germany 
C18 bond Elut LRC Agilent Technology, Santa Clara, USA 
Cell culture CO2 incubator Binder, Tuttlingen, Germany 
Centrifuge (Hettich Universal 32R) DJB labcare, Buckinghamshire, UK 
Confocal microscope Leica Microsystems, Wetzlar, Germany 
Coverslip Roth, Karlsruhe, Germany 
Electrophoresis system PEQLAB, Erlangen, Germany 
Esquire 3000 ESI-ion trap (IT)-MS  Bruker Daltonics, Bremen, Germany 
Fluorescence detector Jasco, Gross-Umstadt, Germany 
Fluorescence detector Merck-Hitachi Darmstadt, Germany 
Gel Jet Imager 2000 documentation system Intas, Göttingen, Germany 
Grease-free slides (SuperFrost) R. Langenbrinck, Emmendingen, 
Germany 
Heat Block  Medax, Kiel, Germany 
HyperSep™ Hypercarb™ SPE Cartridge Thermo Scientific, Waltham, USA 
Laser Capture Microdissection (LCMD) Zeiss, Munich, Germany 
LC system (Smart line) Knauer, Berlin, Germany 
Magnetic stirrer IKA, Staufen, Germany 
Membrane slide Zeiss, Munich, Germany 
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Microtome RM2245 Leica Microsystems, Wetzlar, Germany 
Microwave oven Samsung, Schwalbach, Germany 
Mini centrifuge (Galaxy 14D) VWR, Radnor, USA 
Mixer Mill MM 300 Retsch, Haan, Germany 
NanoDrop ND 2000 Promega, Mannheim, Germany 
Neubauer counting chamber LaborOptik, Marienfeld, Germany 
Normal phase column (CHROMABOND®) Macherey-Nagel, Düren, Germany 
Pall Nanosep®10 kDa filters PALL Life Sciences, Ann Arbor, USA 
pH indicator paper (Whatman) Thermo Fisher, Waltham, USA 
pH Meter Knick, Berlin, Germany 
Power supply units PEQLAB, Erlangen, Germany 
Reversed-phase column (Superspher )  Merck-Hitachi, Darmstadt, Germany 
RNase-free filter tips Nerbe plus, Winsen, Germany 
SpeedVac Thermo Fisher, Waltham, USA 
Steel target  Bruker Daltonics, Bremen, Germany 
Thermocycler Biozyme, Oldendorf, Germany 
Thermo-shaker Eppendorf, Hamburg, Germany 
Thermo-shaker Peqlab, Erlangen, Germany 
Ultraflex I TOF/TOF mass spectrometer Bruker Daltonics, Bremen, Germany 
Ultrasonicator (Ultrasonic bath) Bandelin, Berlin, Germany 
Vacuum manifold (VacMaster™) Biotage, Uppsala, Sweden 
Vortex mixer Janke & Kunkel, Staufen, Germany 
Water purification system Millipore, Darmstadt, Germany 
Weight Mettler, Greifensee, Switzerland 
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2.2   Methods 
2.2.1 Criteria for selection of sperm donors  
All patients and volunteers provided written informed consent for semen analysis. All 
samples were anonymized. As controls, three healthy males of reproductive age (median: 34 
yr; range: 26-44 yr) were recruited during their medical checkup in the outpatient clinic. In 
addition, ejaculates of three patients (median: 40 yr; range: 19-54 yr) suffering acute 
unilateral E. coli-related epididymitis were analyzed within the first 2 weeks after diagnosis. 
Patients were part of the Giessen Epididymitis Study (institutional review board no. 100/7, 
German Clinical Trials Register no. DRKS00003325) and treated according to current 
guideline recommendations [121]. Out of 22 epididymitis patients providing semen, only the 
samples of three patients (aged 19, 54, and 47) had a suitable sperm concentration (> 0.5 
million/ml) to undergo further analysis. All patients underwent a comprehensive 
microbiological analysis for classical uropathogens by culture and species-specific PCR 
analysis to detect Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, 
and Chlamydia trachomatis. Only healthy donors and patients suffering E. coli epididymitis 
were part of the study. Empiric therapy was initiated with levofloxacin 500 mg q.d. orally for 
10 days. Sexually active men were asked to provide a semen sample 14 days after first 
presentation.  
2.2.2 Isolation of human sperm  
Semen samples were collected by masturbation into a sterile container. Ejaculates were 
liquefied and then semen analysis was performed according to World Health Organization 
(WHO 2010) recommendations [122]. Parameters such as pH, volume, concentration, 
viability and motility were recorded and subsequently assessed. For motility assay, the 
proportion of immotile and progressive motile spermatozoa in semen was defined under a 
light microscope by the average movement status of 100 spermatozoa in two consecutive 
counting experiments. To estimate the vitality of spermatozoa, 10 µl of ejaculate and 10 µl of 
eosin were mixed for 30 sec, and then the ratio of live (unstained) to dead (red head) 
spermatozoa was evaluated following two times random counting processes under a light 
microscope. To select motile sperm, the swim-up procedure was applied [123]. One ml of 
fresh semen sample was placed in a sterile centrifuge tube, and 1 ml of prewarmed (37°C) 
human tubal fluid (HTF) medium was layered over it. The tube was inclined at an angle of 45º 
and incubated for 1 h at 37°C. After incubation, 1 ml of upper medium containing highly 
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motile sperm was removed, diluted with 2 ml of HTF medium and centrifuged at 500 × g for 
5 min. Following spin down, the supernatant was discarded and pellets of all ejaculate 
aliquots containing highly motile spermatozoa were pooled in one tube. Motile spermatozoa 
were diluted in 0.5 ml of HTF medium and counted using a Neubauer counting chamber 
under a light microscope. To prove the success of the swim-up procedure, the motility of 
spermatozoa was assessed following swim-up and compared to sperm motility in semen. The 
diluted fraction of spermatozoa was centrifuged (700 × g, 10 min). Finally, the obtained 
sperm pellet was washed and centrifuged twice with Dulbecco’s phosphate-buffered saline 
(PBS) medium (pH 7.4) at 700 × g for 10 min. 
2.2.3 Bacterial strains and propagation  
The UPEC strain CFT073 used in our study (NCBI Reference Sequence: NC_004431.1, 
GenBank: AE014075.1) was kindly provided by Prof. Chakraborty from the Institute of 
Medical Microbiology, Justus Liebig University of Giessen. Propagation of UPEC was 
performed by overnight (O/N) cultivation of the bacteria on a blood agar plate and then 
inoculation in lysogeny broth (LB) medium. Subsequently, bacteria growing in an exponential 
phase (OD600 = 0.5–1.0) were acquired following incubation at 37°C on a shaker, as previously 
described [35]. The concentration of bacteria was calculated using standard growth curves 
[35, 124]. Following centrifugation at 4,500 × g for 8 min at RT, bacteria were washed by 
PBS. Next, the pellet containing E. coli was diluted in 10 ml of PBS and RPMI 1640 and then 
used for in vivo and in vitro experiments, respectively. 
LB medium (pH 7.4) 
0.5% (w/v)  Yeast extract 
1% (w/v)              Bactotryptophan 
1 M   Sodium chloride (NaCl) 
 
LB-Agar 
1.5%              Bactoagar in LB medium 
 
2.2.4 In vitro infection of human sperm with UPEC 
Isolated spermatozoa after swim-up procedure (~ 7.5 × 106) were mixed with 5 × 105 
UPEC (multiplicity of infection (MOI) ~ 0.07) for 3 h at 37°C and 5% CO2. The pellet (700 × 
g, 10 min) was collected after two washing steps using PBS (pH 7.4). 
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2.2.5 Mouse experimental epididymitis model  
Adult inbred C57BL/6J mice (10-week-old) were purchased from Charles River 
Laboratories (Sulzfeld, Germany). All animal studies were performed according to a German 
protocol for the care and use of laboratory animals approved by the Animal Ethics Committee 
of the Regierungspraesidium Giessen (permit no. GI 18/17–No. 124/2012). Mice were 
euthanized by CO2 inhalation. All attempts were made to diminish suffering. 
 To induce epididymitis, 5-10 µl of PBS suspension containing between 4-8 × 104 bacteria 
were injected bilaterally close to the epididymis into the vas deferens, which was previously 
ligated to prevent retrograde ascend of the bacteria [125, 126]. For sham controls, an equal 
volume of PBS alone was injected into the vas deference of control animals. An ascend of 
UPEC from the injection site to the epididymis was previously demonstrated [24]. Three days 
post-infection, mice were sacrificed and the epididymides were removed. The epididymides 
from one side were snap frozen in liquid nitrogen after cryo-embedding in optimum cutting 
temperature (OCT) media for lectin staining, whilst the epididymides from the contralateral 
side were immediately fixed in Bouin’s solution and embedded in paraffin. Subsequently, 
sections were utilized for histological staining and LCMD. 
2.2.6 Lectin fluorescence staining  
After swim-up freshly prepared human spermatozoa (approximately 50,000 sperm diluted 
in 10 µl PBS) were smeared onto clean grease-free SuperFrost slides and air-dried. Serial 
cryosections (8 μm) were prepared from frozen mouse epididymides. Human spermatozoa 
and mouse epididymis sections were fixed with 2% paraformaldehyde for 30 min. Two % 
paraformaldehyde fixative was prepared by diluting 37% formaldehyde solution in PBS. The 
mouse epididymis caput epithelial cell line (MEPC5) was kindly provided by Dr. Vera Michel 
(Institute of Anatomy and Cell Biology, JLU, Giessen). Cells were grown on glass coverslips 
and fixed in acetone. After fixation sections were washed using PBS and blocked with 0.1% 
bovine serum albumin (BSA) in PBS for 1 h at room temperature (RT). To investigate the 
presence of specific monosaccharides and linkages in sperm and the epididymis, FITC-
conjugated lectins (including PNA, PSA, Maackia amurensis agglutinin (MAA), and 
Sambucus Nigra (SNA)) were used at a final concentration of 10 µg/ml in PBS containing 0.1 
% BSA and incubated for 30 min in a moisture chamber. All FITC-labeled lectins were 
purchased from Vector Laboratories (Burlingame, USA). Subsequently, slides were washed 
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three times with PBS. For visualization of nuclei, slides were incubated with TOPRO®-3 
(dilution 1:1,000; 1 min). To preserve the fluorescence signal during prolonged storage, 25 µl 
of VECTASHIELD® mounting medium was dispensed onto the section and then dispersed 
using a coverslip. Coverslips were sealed to the slide using a transparent nail polish. Images 
were acquired using a laser scanning confocal microscope. Excitation filters were set to 488 
nm to detect FITC (lectins-bound glycostructures) and 633 nm to visualize nuclei with 
Topro®-3. 
2.2.7 Laser capture microdissection  
Paraffin embedded murine epididymides were sectioned (5 µm) using a microtome 
(RM2245) and mounted on membrane slides for LCMD. As previously described, sections 
were sequentially deparaffinized, rehydrated, stained with Mayer’s hematoxylin, washed, 
dehydrated and air-dried (Table 2) [127]. Tissue areas were collected using a 20 × objective 
and dissected in Robo-Laser pressure catapulting (LPC)-mode. To calculate the number of 
dissected cells, stained nuclei by Mayer’s hematoxylin were counted. Isolated area from tissue 
was collected in an adhesive cap. Thereafter, the adhesive caps were cut and transferred into 
glass vials for sialic acid analysis [127, 128]. 
Table 2. Preparation steps for epididymis sections prior to LCMD. Sections were 
deparaffinized, rehydrated, stained, and dehydrated as described below. 
 
Steps Solution Incubation time 
 
 
 
Deparaffinization and rehydration 
100% xylene 5 min 
100% xylene 5 min 
100% ethanol 5 min 
100% ethanol 5 min 
95% ethanol 5 min 
70% ethanol 5 min 
dH20 5 min 
Nuclear staining Mayer’s hematoxylin 30 sec 
Washing Running tab water 15 min 
 
Dehydration 
70% ethanol 5 min 
100% ethanol 5 min 
100% ethanol 5 min 
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2.2.8 Release and DMB-labeling of sialic acids  
Washed spermatozoa obtained after swim-up as well as collected tissue samples were 
subjected to sonication (10 min) and hydrolyzed in 500 μl of 2 N acetic acid for 90 min at 80 
°C, transferred into glass vials, and dried. Fluorescent labeling of sialic acids was performed 
using 80 μl of 4,5-methylenedioxybenzene (DMB)-reaction buffer for 2 h at 55°C, as already 
described [129-132]. Labeling was terminated by adding 20 μl of 0.2 M sodium hydroxide 
(NaOH) [127, 133, 134]. To calculate the amount of Neu5Ac a four-point calibration line was 
generated using different concentrations of Neu5Ac (i.e. 0.005, 0.01, 0.05, and 0.10 nM). 
Acetic acid (2 N) 
4.5 ml                   Glacial acetic acid  
40 ml                    dH2O 
 
DMB-reaction buffer 
1 M                      β-mercaptoethanol 
9 mM                   Sodium hydrosulfite 
20 mM                 Trifluoroacetic acid (TFA) 
2.7 mM                DMB 
 
NaOH (0.2 M) 
0.8 g                     NaOH 
100 ml                  dH2O 
 
2.2.9 HPLC and online HPLC-ESI-MS of DMB-labeled samples 
DMB-labeled sialic acids from spermatozoa and epithelial cells were separated for 
quantification by a reversed-phase column (Superspher 100 C-18e-RP, 250 × 4 mm) at 40°C 
using an Ultimate LC system, which was directly coupled with an Esquire 3000 ESI-ion trap 
(IT)-MS [127, 134]. Fluorescently-labeled sialic acids were separated by applying mobile 
phases (A and B) containing acetonitrile / methanol / water/ TFA (4:4:92:0.1) (v/v) (A) and 
acetonitrile/ methanol/ water/ TFA (45:45:10:0.1) (v/v) (B). The LC method consisted of a 
linear gradient from 0% to 15% (B) in 30 min (Table 3). The flow rate was 250 μl/min over 
60 min. The fluorescence detection settings for extinction (λex) and emission (λem) 
wavelengths were 372 nm and 456 nm, respectively. Typical ESI source conditions were: 
spray voltage 1.4 kV, capillary temperature of 250°C, end plate offset of −500 V, and 
capillary exit of 140 V [127]. Series of samples were injected sequentially using an 
Autosampler (Midas™) equipped with a sample cooling system. 
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Table 3. HPLC gradient program for separation of DMB-labeled samples. Followed by 
fluorescent labeling of spermatozoa and epithelial cells, sialic acids were analyzed using a 55 min 
gradient program. 
 
Time A% B% 
0 100 0 
25 95 5 
30 85 15 
35 0 100 
40 0 100 
55 100 0 
 
2.2.10 In vitro enzymatic desialylation  
To induce a mimicry desialylation, spermatozoa after swim-up were incubated with 5 
mU/ml sialidase (Neuraminidase Vibrio Cholerae) in HTF medium for 3 h at 37°C and 5% 
CO2. Spermatozoa were washed two times using PBS (700 × g, 10 min) and collected in a 
pellet following centrifugation. 
Enzymatic desialylation of epididymis frozen sections was performed in a humidified 
chamber following incubation with 5 mU/ml of sialidase in a sialidase buffer for 1 h at 37°C. 
Afterward, slides were placed at RT and washed three times with PBS for 5 min each [135]. 
Sialidase buffer (pH 5) 
0.1 M                    Sodium acetate  
0.15 M                  Sodium chloride 
 
2.2.11 Inhibition of sperm sialidase  
Desialylation of sperm was inhibited by adding 1 mM N-Acetyl-2,3-dehydro-2-
deoxyneuraminic acid (DANA), which is a specific endogenous neuraminidase inhibitor, to 
HTF medium for 3 h at 37°C and 5% CO2. After treatment, spermatozoa were collected by 
centrifugation (700 × g, 10 min) after two washing steps using PBS. 
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2.2.12 Induction of acrosome reaction  
The acrosome reaction was induced following incubation of spermatozoa for 1 h at 37°C 
and 5% CO2 in HTF medium supplemented with 10 µM calcium ionophore A23187 solution 
dissolved in dimethyl sulfoxide (DMSO) [104]. Following treatment, the suspension was 
centrifuged (700 × g, 10 min). After centrifugation, the pellet of spermatozoa was 
resuspended in PBS buffer (pH 7.4) and washed twice (700 × g, 10 min each). 
2.2.13 Isolation of human sperm N-glycans  
To quantify and profile sperm N-glycans, glycoproteins of spermatozoa were digested to 
glycopeptides. Next, N-glycans were isolated, hydrolyzed, fluorescently labeled and analyzed 
using LC-MS applications. 
2.2.13.1 Protein digestion  
Swim-up sperm samples were washed using PBS and the pellet was resuspended in 50 
mM ammonium bicarbonate (pH 8.5). Subsequently, ultrasonication of sperm sample for 10 
min was performed. Afterward, 1 µl of trypsin solution was added and incubated O/N at 
37°C. Tryptic digestion of sperm glycoproteins to glycopeptides was terminated following 
incubation with 20 µl PMSF solution (containing 100 mM PMSF in isopropanol) for 2 h at 
RT. Inhibition process of trypsin was continued by shaking on a heat block for 10 min at 
100°C. 
Trypsin solution 
1 mg                   Trypsin (from bovine pancreas) 
1 ml                    Hydrochloric acid (HCl) (0.001 M) 
 
2.2.13.2 N-glycan digestion and purification  
After heating, sperm glycopeptides were cooled down at RT for 10 min. Subsequently, N-
glycans were liberated from peptides in a process which was initiated via applying 20 units of 
N-glycosidase F (PNGase F) O/N at 37°C. Afterward, released glycans were collected from 
sperm suspension using a solid phase extraction (SPE) by C18 cartridges. Before running 
through, C18 cartridges were washed and primed via successive administration of 2 ml 
methanol, 2 ml TFA 0.1%, 2 ml 40% acetonitrile, TFA 0.1%, 2 ml 80% acetonitrile, TFA 
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0.1%, 2 ml TFA 0.1%, and 10 ml water. Thereafter, sperm sample was applied onto C18 
cartridge. To release adsorbed N-glycans from C18 cartridge, 4 ml of TFA 0.1% was added 
and eluted fraction was collected in a glass vial. Released N-glycans were condensed to 0.5 
ml volume using a vacuum centrifuge termed as SpeedVac concentrator [136]. 
To increase the purity of N-glycans, 10 kDa molecular weight cutoff filters (Pall 
Nanosep® centrifugal device) were used. Prior to administration of samples, pre-condition 
steps of 10 kDa filters were performed by adding ethanol/ water (50:50) (v/v) followed by 
centrifugation at 13,000 rpm for 5 min and the filtrate was discarded. Subsequently, the 
fraction of N-glycans obtained from SpeedVac was applied on the filter and centrifuged at 
13,000 rpm for 5 min. Next, 100 µl ethanol/ water solution (50:50) (v/v) was added and 
centrifuged twice at 13,000 rpm for 10 min each. Finally, all filtrates were collected and N-
glycans were condensed by drying of the liquid phase via SpeedVac [137]. 
To initiate hydrolysis of liberated glycosylamines to related reducing monosaccharides, 
200 µl of 1% formic acid was added to dried N-glycan sample. Followed by ultrasonication, 
the sample was dried using SpeedVac [137].  
2.2.13.3 Desalting of N-glycans 
Sodium (Na) ions may disturb LC-MS analysis of sperm. Therefore, Na+ ions were 
removed using a Hypercarb cartridge (HyperSep™ Hypercarb™ SPE). To force the liquid 
through the Hypercarb cartridge membrane, the cartridge was placed on a vacuum manifold 
(VacMaster™). Before elution of N-glycans, pre-condition steps were performed via 
successive administration of dH2O and acetonitrile/ 0.1% TFA solutions [136]. 
Precondition steps of Hypercarb cartridges: 
2 ml                      dH2O 
2 ml                      40% acetonitrile/ 0.1% TFA 
2 ml                      80% acetonitrile/ 0.1% TFA  
      10 ml                    dH2O 
 
Dried N-glycans were resuspended in 500 µl dH2O and dissolved with the aid of an 
ultrasonicator. Subsequently, sperm N-glycan solution and 4 ml of dH2O/ 0.1% TFA solution 
were added to the primed cartridge. As a result, the liquid phase containing salts leaves the 
cartridge, but N-glycans bind to the filter. Finally, N-glycans were released in four steps from 
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the Hypercarb cartridge using consecutive administration of acetonitrile/ 0.1% TFA solutions 
as follows: 
Elution steps for releasing of desalted N-glycans from Hypercarb: 
500 µl                   20% acetonitrile/ 0.1% TFA 
500 µl                   40% acetonitrile/ 0.1% TFA     
500 µl                   60% acetonitrile/ 0.1% TFA 
500 µl                   80% acetonitrile/ 0.1% TFA 
 
Following elution steps, obtained fractions containing desalted N-glycans were pulled 
down in a glass vial and then reduced to dryness via SpeedVac [136]. 
2.2.14 Fluorescent labeling of N-glycans 
Fluorescent labeling of sperm N-glycans with 2-aminobenzaminde (2-AB) was performed 
by administration of a 2-AB/ sodium cyanoborohydride (NaBH3CN) reagent to the dried 
glycans. To prepare this reagent, 63 mg of NaBH3CN was dissolved in 1 ml DMSO/ acetic 
acid (77:23) (v/v) mixture containing 48 mg/mL 2-AB. Intense shaking was applied using an 
ultrasonicator and then 50 µl of 2-AB/ NaBH3CN reagent was added to sperm N-glycans. 
After ultrasonication, the vial was placed in a heating block at 65°C for 3 h and later was 
cooled down for 5 min at RT. Subsequently, 90 μl dH2O and 900 μl acetonitrile were added to 
2-AB-labeled glycans and mixed by an ultrasonicator. Unbound 2-AB was removed using a 
normal phase column (CHROMABOND® SiOH). Before loading the sample, pre-
conditioning of the column was performed via consecutive aspiration of 1 ml of dH2O (4X) 
and 1 ml of 95% acetonitrile (4X). After pre-conditioning, the sample was loaded into normal 
phase and the column was eluted 10 times with 1 ml of 95% acetonitrile. Finally, in order to 
separate the labeled N-glycans from the column, 1 ml of dH2O (2X) was introduced to the 
column and flow through collected. The 2-AB-labeled fraction of N-glycans was reduced to 
dryness using a SpeedVac.  
2.2.15 HPLC profiling of 2-AB-labeled N-glycans 
2-AB-labeled N-glycans were separated and quantified under normal phase condition by 
an Amide column (TSKgel Amide-80) at 40°C using an Ultimate LC. Applied mobile phases 
(A and B) consisted of acetonitrile/ ammonium formate (50 mM, pH 4.5). The flow rate was 1 
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ml/min over 70 min. To record 2-AB fluorescent signal, HPLC detector was adjusted to λex = 
330 nm and λem = 420 nm under gain of 1,000.  
Dried 2-AB-labeled glycans were dissolved in 20 µl of 50 mM ammonium formate (pH 
4.5) and then 80 µl acetonitrile under ultrasonication. Subsequently, 10% of the mixture was 
injected using an autosampler and N-glycans were separated in HPLC via a linear gradient 
program from 20% to 100% (B) in 55 min (Table 4). 
Table 4. HPLC gradient program for separation of 2-AB-labeled samples. Following 2-AB 
labeling, sperm N-glycans were separated within 55 min using a 70 min gradient program. 
Time %A %B 
0 80 20 
50 0 100 
55 0 100 
56 80 20 
70 80 20 
Applied mobile phases  
A                          80% acetonitrile/ 20% ammonium formate (50 mM, pH 4.5)  
B                          20% acetonitrile/ 80% ammonium formate (50 mM, pH 4.5) 
  
2.2.16 Enzymatic desialylation of the N-glycan fractions 
Collected HPLC fractions, containing 2-AB-labeled N-glycans of human spermatozoa in 
glass vials, were reduced to dryness in a SpeedVac and dissolved in 20 µl sodium acetate 
buffer (50 mM, pH 5) by 3 min ultrasonication. Five mU/ml sialidase (Neuraminidase) were 
added to the glass vial and incubated for 15 h at 37°C. After incubation, the sample was dried 
and dissolved two times with 50 µl methanol followed by evaporation in a SpeedVac [138]. 
Desialylated N-glycans and untreated control samples were mixed with 10 µl ammonium 
formate (50 mM, pH 4.5) and 30 µl acetonitrile. Following 3 min ultrasonication, 50% of the 
sample was injected into the HPLC column. Desialylated and control samples were separated 
using HPLC via the same linear gradient program that was designed for the analysis of 2-AB-
labeled samples (Table 4) from 20% to 100% (B) in 55 min under a gain of 1,000. 
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2.2.17 Permethylation of N-glycans 
Dried sperm N-glycans were dissolved via an ultrasonicator in 500 µl of reduction buffer 
inside a screw-capped glass vial. After dissolving, the cap of glass vial was loosely closed and 
stored O/N in darkness at RT. In order to terminate the reduction, a few drops of acetic acid 
were added to the cooled down vial, placed on an ice container, until pH decreased to five. 
Appropriate pH was controlled either using a pH indicator paper or visually since the 
generation of bubbles in reaction with acetic acid in pH 5 were totally ceased. The liquid 
phase was evaporated in a SpeedVac. The condensed sample was subjected to 500 µl 
methanol thrice followed by strong agitation using an ultrasonicator and evaporation under a 
nitrogen stream. Possible salt contamination was removed using a Hypercarb cartridge, as 
previously described (in 2.2.13.3). To proceed the permethylation of desalted and lyophilized 
N-glycans, 300 µl DMSO was added to the vial. In addition to DMSO, a tiny amount (a 
spatula tip) of smashed NaOH under a stream of argon was introduced to the vial. 
Subsequently, the contents of the glass vial were mixed using a vortex for 5 min followed by 
spinning down at 2,500 × g for 1 min. Fifty µl of methyl iodide was introduced to the mixture. 
After 5 min vortexing, the sample vial was shaken for 40 min at RT. Subsequently, the vial 
was cooled down (using an ice bath) in order to prepare the required temperature for 
incubation with 1 ml 10% acetic acid together with 1 ml of dichloromethane. To extract 
permethylated glycans into the organic phase, samples were vortexed (5 min) and spun down 
(2,500 × g, 1 min). The water phase removed. 1 ml 10% acetic acid was mixed with the 
organic layer using 5 min vortex. After 1 min centrifugation (2,500 × g), the water layer was 
discarded. The organic layer was washed using 1 ml dH2O four times, spun down (2,500 × g 
for 1 min each). After every centrifugation step, the water phase was discarded. Separation of 
organic phase from the remaining water was further continued after 30 min incubation of the 
glass vial at -20°C. The organic phase containing permethylated glycans of sperm was 
conveyed to another vial and dried using a nitrogen stream [136]. 
Reduction buffer  
10 mg                   NaBH4  
1 ml                      NaOH (0.01 M) 
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2.2.18 MALDI-TOF-MS 
To identify N-glycan structures of sperm, permethylated N-glycans were analyzed via 
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF). For MALDI-TOF-
MS analysis, the sample was mixed with the matrix solution. The matrix contains crystallized 
molecules which adsorb the energy of laser and conduct it to sample. Subsequently, the 
matrix triggers desorption of the analyte molecules. 2,5-dihydrobenzoic acid (DHB) was 
chosen as a common matrix for glycan analysis with more resistance upon contaminants. To 
prepare DHB solution, 20 mg DHB was dissolved in 1 ml of methanol/ water at a ratio of 
70:30 (v/v) [105]. Permethylated N-glycans were dissolved in 15 µl of 50% methanol 
followed by ultrasonication. Next, a mixture of 1 µl of sample and 1 µl of DHB solution was 
made and applied to a stainless steel target. The sample and the matrix were mixed via 
pipetting and later air dried. N-glycan masses were analyzed using an Ultraflex I TOF/TOF 
mass spectrometer supplied with a nitrogen laser and a LIFT-MS/MS (tandem mass 
spectrometry) facilities. The spectrometer was operated in positive-ion reflector mode for 
detection of permethylated glycans. To control the MALDI-TOF instrument, FlexControl 2.4 
software was utilized. Flex Analysis software 3.0 processed the raw data and analyzed the 
acquired MS and MS/MS spectra. All described software were purchased from Bruker 
Daltonics (Bremen, Germany). The setting was calibrated externally using a standard peptide. 
To acquire sum spectra, 200-400 single spectra were accumulated for parent ion signal and 
fragments. In order to identify the N-glycans, GlycoWorkbench software was applied to 
match MS and MS/MS data with possible glycan structure available at the glycan databases as 
well as to draw glycan compositions used in the annotation of MS and MS/MS spectra. 
2.2.19 Analysis of gene expression by RT-PCR 
Reverse transcription polymerase chain reaction (RT-PCR) copies defined sequences from 
a cDNA and can be used to determine if expression of specific genes occur in a tissue or cell. 
Therefore, expression levels of different O-glycan synthesis genes were investigated in the 
mouse epididymis using RT-PCR. To do so, ribonucleic acid (RNA) was isolated from tissue, 
quantified, reverse transcribed to complementary DNA (cDNA), amplified by PCR, and 
visualized using electrophoresis separation. 
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2.2.19.1 RNA isolation 
RNA was isolated from ≤ 5 mg mouse epididymis tissue using PureLink® RNA Mini Kit 
according to the manufacturer’s protocol. To avoid RNase contamination, RNase-free filter 
tips and tubes were utilized in the entire process of RNA isolation. Prior to lysis, 1% β-
mercaptoethanol was added to the lysis buffer (containing guanidinium isothiocyanate). The 
epididymis was homogenized and lyzed for 3 min in 300 µl of the lysis buffer together with 
metal beads using a homogenizer (TissueLyser). The supernatant was transferred to a new 
vial and an equal volume of 70% ethanol was added and vortexed shortly. The lysed sample 
was applied to a spin cartridge and centrifuged (12,000 × g, 15 sec, RT). The flow-through 
was discarded and again the same amount of 70% ethanol was added to the cartridge followed 
by centrifugation (12,000 × g, 15 sec, RT). 700 µl of wash buffer І was administered to the 
spin cartridge. After spin down (12,000 × g, 15 sec, RT), the flow-through was discarded. The 
cartridge was inserted into a new collection tube and 500 µl of wash buffer ІІ was added to 
the cartridge followed by centrifugation (12,000 × g, 15 sec, RT). The addition of wash buffer 
ІІ and centrifugation was repeated. In order to dry the membrane containing bound RNA, the 
cartridge was spun down at 12,000 × g for 2 min. A recovery tube was inserted instead of the 
collection tube and then 50 µl of RNase-free water layered in the center of the cartridge 
followed by 1 min incubation at RT. To release RNA from the membrane of the cartridge, the 
cartridge was centrifuged at 12,000 × g for 2 min at RT. RNA concentration was measured 
using a NanoDrop. Finally, RNA samples were stored at -80°C. 
To eliminate possible DNA contamination, isolated RNA was incubated with 
Deoxyribonuclease I (DNase I). For this purpose, 1 µg of RNA was mixed with 1 µl of DNase 
I (1 U/µl), 1 µl of reaction buffer, and DEPC-treated water to 10 µl. The mixture was 
incubated for 15 min at RT. Next, DNase was inactivated by administration of 1 µl EDTA (25 
mM) to the tube followed by 10 min heating at 65°C. Absence of DNA contamination in 
RNA sample after digestion with DNase was proved by PCR for β-actin (as a housekeeping 
gene) using RNA sample as template.  
2.2.19.2 cDNA synthesis 
Isolated RNA was reverse transcribed to complementary DNA (cDNA) by Moloney 
Murine Leukemia Virus (M-MLV) reverse transcriptase. RNA was incubated with 2 µl oligo 
dT in a total volume of 21 µl and denatured at 70°C for 10 min. Thereafter, the denatured 
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RNA vial was kept on ice. The reverse transcription master mix was prepared (Table 5) and 
heated for 2 min at 42°C. RNA degradation was avoided using a RNase inhibitor (RNAsin®) 
in the master mix. To synthesize cDNA, the master mix was added to the denatured RNA vial 
and incubated for 75 min at 42°C followed by 15 min at 70°C. Finally, cDNA samples were 
stored at -20°C. 
 
Table 5. cDNA synthesis master mix. Reverse transcription of denatured RNA was performed 
using a combination of the following materials. 
Material Volume (µl) 
RT buffer 5x 8 
dNTP 2 
RNAsin 40 U/ µl 1 
dH2O 4 
M-MLV 1 
 
2.2.19.3 PCR 
The quality of synthesized cDNA was checked via performing PCR for β-actin. First, a 
master mix was prepared (Table 6), containing β-actin primers (forward primer (F): 
ATGGTGGGTATGGGTCAGAA and reverse primer (R): GGGTCATCTTTTCACGGTTG). 
Afterward, DNA was amplified using a thermocycler with described conditions (Table 7). 
Table 6. List of PCR components. PCR master mix was prepared using the following materials: 
 
Material Volume (µl) 
H2O 16.75 
Taq buffer (5x) 5 
MgCl2 1 
dNTP (10 Mm) 0.5 
Primer mix 0.5 
cDNA 1 
Taq polymerase  0.25 
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 Table 7. PCR program for β-actin. β-actin PCR was performed using a thermocycler according 
to outlined program. 
Cycle Temperature Time 
1 94°C  4 min 
25 
94°C          30 sec 
60°C   30 sec 
72°C   30 sec 
1 72°C   10 min 
 
To identify the expression of O-glycan synthesis genes in the epididymis, PCR was 
performed on four types of initiating enzymes in the synthesis of O-glycans, including N-
acetylgalactosaminyltransferases (Galt), N-acetylgalactosaminyltransferases-like (Galtl), 
protein O-fucosyltransferases (Pofut) and protein O-mannosyltransferases (Pomt), using 21 
pairs of primers (Table 8). Selected primers were designed via the “Primer-BLAST” tool at 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/. All applied primers were purchased from 
Life Technologies (Invitrogen). 
Table 8. List of PCR primers. Primers that were used in PCR to investigate the expression of the 
initiating enzymes in the biosynthesis of O-glycans. Williams-Beuren syndrome chromosome region 
17 (Wbscr17) gene is also known by other names: Galnt16, Galnt20, Galntl3, GalNAcT17, and 
GalNAc-T5L. 
 
Gene Primer Sequences (5´→ 3´) PubMed Accession No. 
Product 
length (bp) 
Galnt1 
F: GACTCGCCGAGGCTTTACTC 
R: AGTCATAGCCCCAAAGTGGC 
NM_013814.3 112 
Galntl1 
F: TCGACGTCATCAGCTTGGAC 
R: GGTTTAGTGGGGTCAGTCCG 
NM_001081421.1 139 
Galnt2 
F: ACTTCGCGGATGGAGTTGTT 
R: CGAACGGTCCACCACAGTAA 
NM_139272.2 125 
Galntl2 
F: TGGCCGTGGACAGACATTAC 
R: ACTCGAGAGCAGGGAAGGAT 
NM_030166.3 139 
Galnt3 
F: CCGAGACGCTCACGTTCTTA 
R: CTCACCACGGCAGTGTAGTT 
NM_015736.2 100 
Galnt4 
F: ACCCTACGGGGGCTAATCTT 
R: CCGTCTTTGGGGCAGTTTTG 
NM_015737.4 169 
Galntl4 
F: ATGCCCACGTGGAGTTCAAT 
R: TTTAGGTAGCGGCACCACAG 
NM_173739.3 178 
Galnt5 
F: CCAGTCATGGCAGGTGGATT 
R: CCACTCTGGAACAGGGGATG 
NM_172855.3 163 
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Galntl5 
F: TACTGCGAGTGGTTCACGTC 
R:  CCTTAATTCCACGCGCTCAC 
NM_026449.3 113 
Galnt6 
F: CGTCGGGAAACCCACGAG  
R: CTCTCTGGATCCAATCCGG  
NM_001161767.1 139 
Galnt7 
F: CTTGATGCCCACTGTGAGG  
R: ACCACCCCCTTGGGGTATAA 
NM_144731.4 141 
Galnt10 
F: TTTCCCCAGCGTGAGGATTC 
R: ACACGATGGTCTTCCGGTTC 
NM_134189.2 182 
Galnt11 
F: CCTGGAGCGCCGCTATC 
R: CAGAACTGTCCAGGTAGCAGA 
NM_144908.3 143 
Galnt12 
F: CTACTACCACCGCAATCCCC 
R: CTCTGGCACGTGCAATTCTG 
NM_172693.3 139 
Galnt13 
F: TATCCGGACTCCCAGATCCC  
R: ATCCAGGCACAAGTCGTCAG 
NM_173030.2 198 
Galnt14 
F: TTCCGAGTGTGGATGTGTGG 
R: AAAAGGCCGAGCTGCATAGT 
NM_027864.2 189 
Wbscr17 
F: CTTCGTGAATGAGGCCCTGT 
R: GGGTAGCGTTTGTGGACGTA 
NM_145218.3 159 
Pofut1 
F: ATTTGCGAAGCTGCTGAACC 
R: GGAGGGTGCCAGATTTTCCA 
NM_080463.3 178 
Pofut2 
F: GTCGCGCCTGTCCTCTTAAA 
R: TGCTGGCTCCTAAACTCGTC 
NM_030262.3 167 
Pomt1 
F: TGACTGGCCTGGGACTACTT 
R: AAATGGTGGCCCACTGTCAT 
NM_145145.1 140 
Pomt2 
F: TGCTCACATCTGTTGGGATGA 
R: GCTGTGGTGCTCGTATCTGT 
NM_153415.3 184 
 
1.25% agarose gel was made in Tris-acetate- EDTA (TAE) buffer supplemented with 2-4 
drops (based on the size of gel) of 0.5% ethidium bromide solution (as a fluorescent tag for 
DNA staining). Amplified PCR products mixed with a loading buffer were loaded into wells 
of agarose gel and separated using an electrophoresis system at 100 V for 30 min. Finally, 
separated PCR products were visualized under UV light and photographed using a gel 
documentation system.  
TAE buffer 
40 mM     Tris-acetate  
1 mM       EDTA (pH 8) 
 
Loading buffer (6x) 
0.25% (w/v)          Bromophenol blue  
30%                       Glycerol  
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2.2.20 Statistical analysis  
HPLC data were analyzed by utilizing two tailed-paired Student t-test. P-values ≤ 0.05 
were considered statistically significant. All indicated values are means ± S.E. from at least 
three independent experiments. The sample size was estimated using a post hoc G*Power 
analysis. 
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3 RESULTS 
3.1 Premature acrosome reaction in the mouse epididymitis model 
In order to elucidate if the UPEC-induced acrosome reaction leads to an activation of 
endogenous sialidases initiating a subsequent desialylation of spermatozoa, the established 
mouse epididymitis model was utilized [126]. Lectin fluorescence staining of frozen cauda 
sections from mouse epididymides by FITC-PNA, a lectin with affinity to Gal-β(1-3)-
GalNAc. FITC-PNA is commonly used to detect the acrosome in sperm. Staining revealed 
that a substantial number of spermatozoa have prematurely lost their acrosomes in the 
epididymitis mouse model three days post UPEC infection compared to untreated and PBS 
sham controls (Figure 12). Premature acrosome reaction in the majority of spermatozoa in the 
lumen of the epididymis following UPEC infection (Figure 12) is in accordance with previous 
findings [24]. In contrast, in untreated and sham controls, the acrosomes were intact in most 
spermatozoa. 
 
Figure 12. UPEC-caused premature acrosome reaction in epididymal spermatozoa. 
Acrosomes were stained with PNA-FITC lectin (green) and nuclei were counterstained using TO-
PRO-3 (red) in cauda epididymides from mice 3 days post-UPEC treatment, PBS sham controls, and 
untreated controls. Inserts in the first row were magnified digitally and are shown in the second row 
[28]. (Copyright © 2016, by the American Society for Biochemistry and Molecular Biology) 
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3.2 Presence of both α2,3- and α2,6-linked sialic acids in epididymal sperm and 
epithelial cells 
To gain a first insight into the sialylation status of epididymal spermatozoa and epithelial 
cells, α2,3- and α2,6-linked sialic acid residues were visualized on epididymal sections using 
FITC-conjugated MAA (Figure 13) and SNA (Figure 14) lectins, respectively. As control, 
sections were labeled after in vitro sialidase treatment. A reduced fluorescence signal in 
sialidase treated sections confirmed the specific occurrence of Neu5Ac residues in both types 
of α2,3- and α2,6-linked sialic acids in caudal spermatozoa, epithelial cells, and epididymal 
fluid.  
 
 
 
Figure 13. Presence of α2,3-linked sialic acid residues in caudal spermatozoa and epididymal 
epithelial cells. α 2,3-linked sialic acid residues were visualized by MAA-FITC lectin (green) in 
sections from the epididymis of control mouse prior and following in vitro sialidase treatment. Nuclei 
were counterstained with TO-PRO-3 (red). In contrast to untreated control, sialidase-treated sections 
showed a weaker and diffused signal of sialic acid labeling in spermatozoa, epithelial cells, and 
luminal fluid. Images in the lower row were magnified digitally from the frames in the upper row. 
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Figure 14. Presence of α2,6-linked sialic acid residues in caudal spermatozoa and epithelial 
cells. α 2,6-linked sialic acid residues were visualized by SNA-FITC lectin (green) in sections from 
the epididymis of control mouse (untreated) prior and following in vitro sialidase treatment (untreated 
+ sialidase). Nuclei were counterstained with TO-PRO-3 (red). In contrast to untreated, sialidase-
treated sections showed a weaker and diffused signal of sialic acid labeling in spermatozoa and 
luminal fluid. Images in the lower row were magnified digitally. 
 
To confirm the presence of sialic acids in epithelial cells of the epididymis, a mouse 
epididymis proximal caput (MEPC5) cell line was stained with SNA and MAA (Figure 15). 
Consistent with the observed affinity of epididymis sections to sialic acid-specific lectins 
(Figures 13 and 14), MEPC5 cell staining also demonstrated the substantial presence of both 
α2,3- and α2,6-linked sialic acid residues (Figure 15).  
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Figure 15. Association of both α2,3- and α2,6-linked sialic acid residues with epidydimal 
epithelial cells. The cells of the MEPC5 cell line from mouse proximal caput were acetone fixed. 
Then α2,6- and α2,3-linked sialic acids were visualized using SNA and MAA lectins, respectively 
(green). Nuclei were counterstained with TO-PRO-3 (red). Images were acquired using a confocal 
microscope and frames in the upper row were magnified in the lower row digitally. 
 
3.3 Redecoration of α2,6-linked sialic acids of sperm in the mouse epididymitis model 
To elucidate the status of α2,6-linked sialylation after UPEC infection, FITC-conjugated 
SNA lectin was employed on epididymal sections (Figure 16). Fluorescence microscopy 
revealed a diffusely distributed and weaker SNA labeling in spermatozoa of UPEC infected 
mice, whilst in untreated and sham controls prominent staining of α2,6-linked sialic acid 
residues was evident in the acrosome and sperm tail (Figure 16). The reduced SNA staining in 
UPEC treated mice suggested that Neu5Ac residues were cleaved during infection. 
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Figure 16. Decreased content of α2,6-linked sialic acid in caudal spermatozoa after UPEC 
epididymitis. α2,6-linked sialic acid residues were visualized by SNA-FITC lectin (green) and nuclei 
were counterstained with TO-PRO-3 (red) in sections from the mouse epididymis 3 days post UPEC 
infection, PBS sham control and untreated control. In contrast to untreated and sham controls, in 
UPEC infection a more diffuse sialic acid labeling is evident. Images in the lower row were magnified 
digitally from the frames seen in the upper row [28]. (Copyright © 2016, by the American Society for 
Biochemistry and Molecular Biology) 
 
 
3.4 No evident alterations in α2,3-linked sialic acids of sperm in the mouse   
epididymitis model 
SNA prevalently binds α2,6-linked sialic acid residues. However, α2,3-linked sialic acid 
residues may also be detected by this lectin, although to a lesser degree. Therefore, to clarify 
the status of α2,3-linked sialic acids in sperm and epithelial cells, cauda epididymal sections 
from 3 days UPEC treated, untreated and sham control mice were stained using FITC-
conjugated MAA lectin. Unlike α2,6-linked sialic acids (Figure 16), the presence of α2,3-
linked sialic acids in sperm and epithelial cells failed to be altered substantially after UPEC 
infection (Figure 17).  
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Figure 17. Unchanged presence of α2,3-linked sialic acids in caudal spermatozoa after UPEC 
epididymitis. α2,3-linked sialic acid residues were visualized by MAA-FITC lectin (green) and nuclei 
were counterstained with TO-PRO-3 (red) in sections from the mouse epididymis 3 days post UPEC 
infection and from untreated control. Untreated and UPEC infection staining showed a similar pattern 
of α2,3-linked sialic acid labeling and no evident differences in fluorescence signal were observed. 
Images in the lower row were magnified digitally from the frames above. 
 
3.5 Reduction of sialic acid content in epididymal sperm in the mouse epididymitis 
model 
Since qualitative as well as quantitative lectin analysis of sialic acids are often misleading 
and SNA lectin visualizes only a fraction of sialic acid residues on glycoconjugates, a recently 
developed combination of LCMD and DMB-HPLC-ESI-MS analysis was applied (Figure 18) 
[127]. Starting from murine paraffin embedded tissue samples, epididymal spermatozoa were 
isolated via LCMD after nuclear staining using Mayer’s hematoxylin (Figure 18A, B). 
Thereafter, sialic acids were released under acidic conditions, fluorescently labeled and 
subjected to a HPLC-ESI-MS system. The obtained chromatograms showed smaller peaks of 
DMB-labeled Neu5Ac in infected material (Figure 18C). The respective DMB-Neu5Ac mass 
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at m/z 448 [M + Na]+ in the ESI-MS spectrum verified the presence of DMB-Neu5Ac during 
the corresponding retention time of a DMB-Neu5Ac standard (Figure 18C). Calculation of 
corresponding peak areas demonstrated a significant reduction of Neu5Ac (~ 19%) in 
spermatozoa in UPEC epididymitis (Figure 18D). 
 
 
Figure 18. Desialylation of epididymal spermatozoa following UPEC infection. (A) 
Spermatozoa from the epididymal lumen were isolated by laser microdissection from hematoxylin 
stained paraffin embedded tissue sections. Excised area is indicated by the black arrow and green 
circle. Scale bar = 150 μm. (B) Same section after excision of luminal content. (C) Obtained 
spermatozoa were subsequently used for sialic acid quantification. After hydrolysis and fluorescent 
labeling, DMB-sialic acid residues were separated using RP-HPLC. A set of sialic acid standards was 
used for the generation of a calibration line and to control the retention times. ESI-MS spectra were 
recorded during the HPLC runs to verify the presence of different sialic acid species as shown 
exemplary for Neu5Ac in UPEC treated and PBS sham control epididymides. (D) The amounts of 
Neu5Ac and the respective standard deviations (S.D.) were calculated from four epididymides 
obtained from PBS sham control and UPEC injected mice, respectively (n= 4 animals). Given mean 
values were set to 100% for sham control. The statistical evaluation was performed using Student’s t-
test (unequal variances, two tailed). Significance levels are classified as follows *, p ≤ 0.05. KDN= 2-
keto-3-deoxynononic acid, Neu5Ac=N-acetylneuraminic acid, Neu5Gc=N-glycolylneuraminic acid 
[28]. (Copyright © 2016, by the American Society for Biochemistry and Molecular Biology) 
 
3.6 Sialic acid loss in epididymal epithelial cells in the mouse epididymitis model 
Release of sialic acids from the spermatozoa to the luminal fluid following UPEC 
infection could be enzymatically mediated by soluble sialidases, a hypothesis supported by an 
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observation of Ma et al. [16], who described that the sialidases NEU1 and NEU3 are released 
from the cell surface of spermatozoa after proteolytic activation. Consequently, soluble 
neuraminidases would be also able to affect the cell surface of surrounding cells. To test this 
hypothesis, the sialylation status of epididymal epithelial cells − whose apical surface borders 
to the luminal fluid − was analyzed using the above mentioned combined LCMD/DMB-
HPLC-ESI-MS strategy (Figure 19). In support, epididymal epithelial cells showed a 
reduction of sialic acid residues (~ 49%) 3 days post infection with UPEC compared to sham 
(Figure 19C, D). Reduction of Neu5Ac from epithelial cells is substantially stronger in 
comparison to spermatozoa (Figure 18). 
 
 
Figure 19. Reduction of sialic acid content in epithelial cells in UPEC epididymitis. (A) 
Epithelial cells were isolated from paraffin embedded mouse epididymis by laser microdissection. 
Excised area is indicated by the black arrow and green line. (B) Same section after excision of 
epithelium. Scale bar = 150 μm. (C) DMB-labeled sialic acid residues of the isolated cells were 
separated using RP-HPLC. A set of sialic acid standards was used for quantification and to control the 
retention times. ESI-MS spectrum was recorded during the HPLC runs (data not shown). (D) The 
amounts of Neu5Ac and the respective S.D. of 5 different controls and infected mice (one epididymis 
from five animals each). Given mean values were set to 100% for sham control. Significance levels 
are classified as follows *, p ≤ 0.05. KDN= 2-keto-3-deoxynononic acid, Neu5Ac=N-acetylneuraminic 
acid, Neu5Gc=N-glycolylneuraminic acid [28]. (Copyright © 2016, by the American Society for 
Biochemistry and Molecular Biology) 
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Thus, the obtained results demonstrate that the sialylation status of epididymal 
spermatozoa in the lumen as well as that of the lumen lining epithelial cells decrease in the 
epididymis after bacterial infection. 
3.7 Presence of KDO in UPEC 
Whereas in UPEC treated samples a peak for DMB-Neu5Gc was apparent in the HPLC-
chromatogram, in sham control hardly any signal was detectable. However, no mass 
corresponding to DMB-Neu5Gc was obtained by ESI-MS in untreated as well as infected 
mice (data not shown). Due to the fact that DMB reacts with all α-keto acids, possible 
contamination in infected mice by α-keto acids originating from the pathogen was examined 
by separate analysis of bacteria only. In UPEC, the presence of DMB-labeled 3-Deoxy-D-
manno-oct-2-ulosonic acid (KDO) − a well-known bacterial α-keto acid [77] − was 
measurable as a prominent peak at the retention time of DMB-Neu5Gc (Figure 20). In 
addition, KDO-related monoisotopic pseudomolecular masses of DMB-KDO at m/z 337 ([M 
+ H]+ - H2O), 355 ([M + H]+), and 377 ([M + Na]+) were monitored in the ESI-MS spectrum 
at this particular time. Thus, in UPEC treated mice bacterial KDO was obviously recorded at 
the retention time of DMB-Neu5Gc (Figure 20). 
 
Figure 20. Analysis of α-keto acids in UPEC. (A) Sialic acid standards and UPEC samples were 
hydrolyzed and α-keto acids were fluorescently labeled with DMB for HPLC separation. (B) ESI-MS 
spectrum recorded during the elution time of the peak is highlighted by the red dotted frame. KDN= 2-
keto-3-deoxynononic acid [28]. (Copyright © 2016, by the American Society for Biochemistry and 
Molecular Biology) 
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3.8  Hyposialylation of spermatozoa after chemical induction of acrosome reaction 
To investigate the correlation of the acrosome reaction, a process which untimely occurs 
in epididymitis, with sperm hyposialylation, acrosomal exocytosis in human sperm was 
artificially induced using a calcium ionophore chemical (A23187). The obtained HPLC 
chromatograms showed an attenuated fluorescence intensity of DMB-labeled Neu5Ac in 
ionophore treated spermatozoa compared to untreated controls (Figure 21A), indicating a 
significant reduction in sperm sialic acids after induction of the acrosome reaction (Figure 
21B).  
 
 
 
 
Figure 21. Reduced amounts of sialic acids after acrosome reaction in human sperm. Human 
spermatozoa from swim-up ejaculates of healthy individuals were acrosomally reacted using the 
ionophore A23187. (A) After hydrolysis and fluorescence labeling, DMB-sialic acid residues were 
isolated by RP-HPLC. (B) The amount of Neu5Ac was compared between untreated and ionophore-
treated portions. Given mean values were set to 100% for untreated control sperm. The statistical 
evaluation was performed using Student’s t-test (unequal variances, two tailed). *, p ≤ 0.05; n=3. 
 
3.9 Premature acrosome reaction in human sperm caused by UPEC infection 
In order to investigate if UPEC can also induce hyposialylation in human spermatozoa, 
motile spermatozoa of healthy donors collected after swim-up were subsequently infected 
with UPEC. PSA-FITC lectin staining detected a substantially higher number of completely 
or partially acrosome reacted spermatozoa in UPEC treated spermatozoa (Figure 22).  
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Figure 22. Increased acrosome reaction in human spermatozoa after UPEC infection in vitro. 
Following swim-up, spermatozoa were incubated with UPEC. The acrosomes were labeled by PSA-
FITC lectin (green) and nuclei were counterstained with TO-PRO-3 (red). Presence of the acrosome 
was compared to untreated control [28]. (Copyright © 2016 by the American Society for Biochemistry 
and Molecular Biology) 
 
3.10 Sperm desialylation as a consequence of UPEC infection 
In order to investigate if UPEC can also induce hyposialylation in human spermatozoa, 
motile spermatozoa of healthy donors collected after swim-up were subsequently infected 
with UPEC for 3 h, and the sialylation status was quantified by HPLC (Figure 23). DMB-
HPLC analysis demonstrated a significant reduction in the amount of Neu5Ac following 
UPEC infection compared to untreated control. As a positive control, neuraminidase was 
added for 3 h. Accordingly, hyposialylation of sperm (both in presence and absence of UPEC) 
after incubation with neuraminidase increased substantially compared to controls devoid of 
neuraminidase (Figure 23). 
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Figure 23. Decreased content of human sperm sialic acid after UPEC treatment. Human 
spermatozoa from swim-up ejaculates of healthy donors were treated with UPEC for 3 h in vitro and 
then for 3 h with neuraminidase. (A) After hydrolysis and fluorescence labeling DMB-sialic acid 
residues were isolated by RP-HPLC. (B) The amount of Neu5Ac was compared between untreated 
and UPEC and/or neuraminidase-treated portions. Given mean values were set to 100% for untreated 
control. The statistical evaluation was performed using Student’s t-test (unequal variances, two tailed). 
Significance levels are classified as follows: *, p ≤ 0.05, **, p ≤ 0.01, ns, not significant (n:3). 
 
3.11 Counteracting of sperm in vitro desialylation with sialidase inhibitors 
To examine if the investigated hyposialylation of spermatozoa is mostly the consequence 
of a general loss of glycoconjugates (e.g. due to the degradation of the glycoprotein 
backbone) or alternatively the activation of neuraminidases during the acrosome reaction, 
motile human spermatozoa were treated with UPEC in the presence of the sialidase inhibitor 
DANA (Figure 24). Here, co-incubation of DANA with UPEC prevented hyposialylation of 
human spermatozoa completely (Figure 24). Consequently, the decreased sialylation values 
are based on the enzymatic activity of released endogenous sialidases. A bacterial sialidase 
activity could be excluded by in silico analysis of the UPEC genome. 
Consequently, the decreased sialylation status in infected spermatozoa is likely based on 
the enzymatic activity of released sialidases. 
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Figure 24. Counteraction of UPEC dependent desialylation of human spermatozoa by a 
sialidase inhibitor in vitro. Spermatozoa from healthy donors prepared by swim-up were incubated 
with UPEC for 3 hours and the amount of Neu5Ac was compared with untreated samples using the 
DMB-HPLC approach as shown in figure 18. In parallel, UPEC treated as well as untreated 
spermatozoa were co-incubated with the sialidase inhibitor DANA. Given mean values were set to 
100% for untreated controls. Significance levels are classified as follows: *, p ≤ 0.05; ns, not 
significant. n=3. 
3.12 Acrosome malformation in epididymitis patients 
 
In addition, semen samples of patients suffering E. coli epididymitis were included in our 
study. For this purpose, spermatozoa were obtained by swim-up from ejaculates of men 14 
days after diagnosis and treatment of E. coli based unilateral epididymitis. The analyzed 
samples showed malformation (in sperm head), and the acrosomes are mainly reacted 
(partially or completely, visualized by PSA-FITC staining) in epididymitis patients compared 
to intact acrosomes of healthy controls (Figure 25). 
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Figure 25. Impaired acrosome integrity in spermatozoa of epididymitis patients. Acrosomes 
of swim-up spermatozoa obtained from healthy men (control) and patients 14 days after diagnosis and 
treatment of acute epididymitis were visualized by PSA-FITC lectin (green). Nuclei were 
counterstained with TO-PRO-3 (red) [28]. (Copyright © 2016 by the American Society for 
Biochemistry and Molecular Biology) 
 
3.13 Hyposialylation in sperm of men with a recent history of epididymitis 
Patients suffering E. coli epididymitis showed much lower levels of Neu5Ac (~ 75% 
reduction) than healthy control spermatozoa (Figure 26). Thus, in agreement with the 
determined loss of sialic acid residues in the mouse epididymitis model and in the in vitro 
experiments, spermatozoa of epididymitis patients are also hyposialylated. 
 
 
Figure 26. Reduced levels of Neu5Ac in patients with a history of acute epididymitis. Sialic 
acid residues of isolated spermatozoa from these patient groups (n=3) were released and fluorescently 
labeled with DMB for quantification. The statistical evaluation was performed using Student’s t-test 
(unequal variances, two tailed). Given mean values were set to 100% for all sham controls. 
Significance levels are classified as follows: *, p ≤ 0.05; ns, not significant [28]. (Copyright © 2016 by 
the American Society for Biochemistry and Molecular Biology) 
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3.14 Contribution of sialylated N-glycans to the sperm glycocalyx 
To identify the presence of sialic acids in the structure of sperm N-glycans, N-glycans 
were isolated from human sperm glycoproteins, fluorescently labeled with 2-AB, and 
separated with HPLC. In parallel, N-glycan isolation and 2-AB labeling efficiency were 
controlled using standard glycoproteins (e.g. fetuin) (Figure 27).  
 
Figure 27.  Establishment of a HPLC method for N-glycan profiling. To analyze N-glycans, 
samples were digested, hydrolyzed, conjugated with 2-AB and injected to HPLC. For this purpose, 
(A) fetuin as a standard glycoprotein (carrying N-glycans) was used as a positive control of the 
system. The red dotted box demonstrates different N-glycan structures of fetuin. (B) To exclude 2-AB- 
related peaks from fractions containing N-glycan, 2-AB was added to sodium acetate buffer and then 
injected to HPLC. (C) To control the purity of HPLC, a blank run was applied. (*) indicates chemical 
peaks, including unbound 2-AB, which was eluted in the beginning and excluded from N-glycan 
analysis.  
 
To separate N-glycans of human spermatozoa, 2-AB-labeled samples were applied to the 
HPLC system (Figure 28A). The putative contribution of sialic acid to the N-glycan 
compositions of each HPLC fraction was investigated using sialidase treatment of the 
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collected fraction. After enzymatic desialylation, these fractions were reinjected to HPLC, 
resulting in detection of 2-3 digested peaks with lower intensities (Figure 28C) from each 
sialylated N-glycan fraction (Figure 28A). Thus, the presence of several sialic acids in the 
structure of corresponding N-glycans could be inferred. In contrast to sialylated N-glycans, 
spermatozoa also contained neutral N-glycans (Figure 28A) including non-sialylated 
structures. Their corresponding chromatograms after the sialidase incubation and reinjection 
remained consistent in retention time, number, and intensity (Figure 28B). 
 
 
 
 
 
 
 
Figure 28. Detection of sialylated and non-sialylated N-glycans in human spermatozoa. (A) 
Spermatozoa after swim-up from healthy donors were subjected to N-glycan isolation and 2-AB 
fluorescence conjugation followed by HPLC analysis. Eluted fractions were collected and incubated 
with 5 mU/ml sialidase for 15 h. (B) Fractions highlighted by dashed box carry neutral non-sialylated 
N-glycans as sialidase treatment failed to alter retention time, intensity, and number of detected peaks 
after HPLC. (C) Fractions highlighted by the solid box contain sialylated N-glycans as shown by the 
occurrence of three lower intensities fractions recorded in different retention time after sialidase 
treatment. 
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3.15 N-glycan profiling of human spermatozoa 
Detection of sialic acids in the structure of sperm N-glycans based on our HPLC analysis 
prompted us to characterize rigorously the compositions of sperm N-glycans. For this 
purpose, 2-AB- labeled N-glycans of sperm from healthy donors were sequenced following 
permethylation using a MALDI-TOF/TOF mass spectrometer in a positive mode (Figure 29). 
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 Figure 29. MALDI-TOF profiling of N-glycan structures in spermatozoa. Following swim-up 
from healthy donors, N-glycans of spermatozoa were isolated (including trypsin and N-glycosidase 
digestion), processed (such as 2-AB labeling, purification, and permethylation), and then analyzed by 
MS. Annotated compositions are according to the molecular mass of positive ion mode of acquired 
spectrum. The proposed compositions are mainly sodiated ([M + Na]+). However, four protonated ([M 
+ H]+) compositions were also registered, and superscripted by a star symbol (*). The intensity was 
normalized to 100% based on the most abundant peak (at m/z 2954). Insert shows a magnification (50 
times) of low signal intensity at m/z range from 3900 to 5500 of the spectrum. 
 
3.15.1 Substantial presence of sialylated N-glycan compositions in human sperm 
According to the MALDI-TOF MS profiling of permethylated derivatives of sperm N-
glycans in a positive ion mode, the highest intensity signal at m/z 2954 [M + Na]+ was 
consistent with a biantennary structure capped with two sialic acid residues (Figure 30A, B). 
This biantennary composition was verified using a MALDI-TOF/TOF fragmentation analysis 
(Figure 30C). In addition, acquired fragment ions (at m/z 2490 and 1912) from MS/MS of the 
precursor peak (at m/z 2954) provided evidence, which let us suggest the occurrence of sialic 
acids in the antennae of this biantennary N-glycan composition (Figure 30C). 
Employing the MALDI-TOF MS profiling strategy, ten possible sialylated N–glycan 
structures were characterized in association with sperm in both complex and hybrid classes of 
N-glycans, terminating with 1-3 sialic acid residues attached to Gal moieties (Figure 31). The 
sialylated complex class of sperm glycans consists of three subclasses, including two 
biantennary (at m/z 2954, and 2967), four triantennary (at m/z 3440, 3765, 3627, and 3801), 
and one tetraantennary (at m/z 4250) structures (Figure 30). In addition to complex structure, 
acquired ions at m/z 4059, 4420, and 4435 were consistent with three hybrid structures 
(Figure 31).  
Two sialylated hybrid compositions (at m/z 4059 and 4220) carry SLex antennae, a critical 
sialylated tetrasaccharide in physiological functions. In addition to the SLex, the presence of 
core Fuc in attachment to GlcNac was detected in six out of ten sialylated N-glycans (at m/z 
2967, 3439, 3800, 4435, 4059, and 4420 (Figure 31). 
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Figure 30. Identification of sialic acid compositions in a disialylated biantennary structure 
associated with human spermatozoa. (A) MS profiling of permethylated 2-AB-labeled N-glycans 
demonstrated a dominant presence of a signal at m/z 2954. (B) The MS spectrum was magnified (50 
times). The peak at m/z 2954 was highlighted by a black dashed box and its corresponding disialylated 
bicentenary composition was annotated according to a positive ion mode ([M + Na]+). (C) MS/MS 
sequencing of m/z 2954 (red dashed line box) generated fragment ions at m/z 2490 (green solid line 
box), 1912 (black solid line box), 1666 (blue solid line box), 824 (brown solid line box) and 792 (pink 
solid line box) which were consistent with the precursor ion assigned sialylated biantennary 
composition in Figure 30B. 
 
 
 
 
 
 
 
Figure 31. Identification of sialylated N-glycans in association with human spermatozoa. 
Data analysis of MALDI-TOF/TOF sequencing (Figure 29) revealed the presence of nine sialylated 
structures. Silalyl-Lewisx (SLex) antennae capped two of the sialylated N-glycan structures 
(highlighted by red dashed boxes). The majority of the adducts have acquired an additional Na ion ([M 
+ Na]+) in the spectrometer, but some of the exceptional adducts, which obtained H cation instead of 
Na ion were denoted by [M + H]+. 
 
3.15.2 Non-sialylated N-glycan compositions of human sperm  
Rigorous MALDI-TOF MS sequencing of associated N-glycans with human sperm 
revealed (Figure 29) that, apart from sialylated structures (Figure 31), several neutral 
compositions occurred in the N-glycome. Characterized non-sialylated structures were 
categorized into two major classes of N-glycans: oligomannose and complex. Oligomannose 
compositions carry between three to nine Man residues in attachment to two GlcNac (at m/z 
1334, 1508, 1538, 1742, 1946, 2150, 2354, 2558) (Figure 32A). In addition to oligomannose 
structures, complex N-glycan were detected in four subclasses, i.e. biantennary (at m/z 1753, 
1998, 2069, 2202, 2243, 2273, 2406, 2447, and 2580) (Figure 32B), bisected biantennary (at 
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m/z 2477, and 2651) (Figure 32B), triantennary (at m/z 2681, 2855, 3304, 3377, 3552, 3726, 
3900) (Figure 32C), and tetraantennary (at m/z 3109, 4013, 4361, 4535, and 4187) (Figure 
32D). The majority of identified tri- and tetraantennary compositions carried Lewisx or Lewisy 
in the outermost position of N-glycans (Figure 32D). 
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Figure 32. Characterization of non-sialylated N-glycans in human sperm. Non-sialylated N-
glycans in human sperm were characterized and divided into four classes. Interpretation of MS data 
from 2-AB-labeled, permethylated N-glycans of human sperm revealed the presence of (A) 
oligomannose structures bearing Fuc0-1-Man3-9-GlcNAc2, (B) biantennary N-glycans carry a Fuc 
residue in most of the identified compositions, two bisected biantennary compositions (highlighted by 
a red box), (C) triantennary, and (D) tetraantennary N-glycans, which were found mainly core-
fucosylated. A sequence of Lewisx (highlighted by blue box) and Lewisy (black box) capped most of 
the tri-  and tetraantennary compositions of human sperm. 
3.16 Alterations of sperm N-glycans as a consequence of the acrosome reaction 
To investigate whether the acrosome reaction coincides with alterations of sperm N-
glycans, human spermatozoa were incubated with a calcium ionophore, as a common inducer 
of the acrosome reaction. Afterwards, N-glycans were isolated, labeled with 2-AB, and then 
separated and analyzed using HPLC (Figure 33A, B). Quantification of 16 obtained N-glycan 
fractions showed alterations in all of the N-glycan structures after ionophore treatment. These 
observed differences in the amounts of all N-glycans may suggest that a massive recordation 
in N-glycan compositions occurs as a consequence of acrosomal exocytosis (Figure 33C).  
First eluted fractions (Peak No. 1 to 7) contained hyposialylated N-glycan structures due 
to their higher intensities in ionophore treated sample. On the other hand, obtained fractions at 
the end of HPLC separation (Peak No. 10 to 16) carried sialylated N-glycans as their 
intensities in untreated spermatozoa were substantially higher compared with ionophore 
treated samples (Figure 33C). Thus, this comparative analysis in the quantity of N-glycan 
fractions between acrosome intact and reacted samples demonstrated that the acrosome 
reaction could manipulate sperm N-glycans, because of the massive shedding of sialic acids 
from the sialylated N-linked glycans. 
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Figure 33. Modifications of N-glycan after induction of acrosome reaction. N-glycans of 
untreated (A) and ionophore-treated (B) human spermatozoa were isolated, fluorescently labeled with 
2-AB and then separated and quantified by HPLC. (C) the relative amount of each N-glycan was 
calculated from the intensity measurement of corresponding HPLC fraction, suggesting a substantial 
alteration in N-glycans structures due to the acrosome reaction (n=3).  
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3.17 Differential expression of O-glycan transferases in the epididymis 
As a first step for future studies on possible O-glycan alterations in the epididymis after 
UPEC infection, we investigated if enzymes related to the biosynthesis of O-glycans are 
expressed in the epididymis. In this regard, in the mouse epididymis we profiled the 
expression levels of 21 different O-glycan transferases from four main types of responsible 
enzymes for initiation of O-glycan synthesis, i.e. Galt, Galtl, Pofut, and Pomt (Figure 34).  
In this regard, a differential expression of O-glycan transferases in the mouse epididymis 
was observed from highly expressed (Galnt12, Galnt14, Galnt10, pofut2, Galntl4) to lowly 
expressed (Galnt1, Galnt13, Galnt3, Galnt11, Galntl2, Galntl5, Galntl3, Pomt1, Pomt2, 
Pofut1, Galntl1) genes. Some genes could not be amplified (Galnt4, Galnt5, Pofut1, Galnt7, 
Galnt6) (Figure 34). Thus, the expression of O-glycan transferase genes may indicate that the 
epididymis plays an active role in the biosynthesis of O-glycans. However, for a precise 
interpretation about the different expression levels of these genes in the epididymis a 
quantitative real-time PCR would be necessary.  
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Figure 34. Different levels of expression of O-glycan transferases in the epididymis. The 
extent of mRNA presence in the epididymis of wild type mouse was investigated among these genes. 
The bands represent the amplification products of a temperature gradient RT-PCR (55-63°C) on 21 
primer sets specific for O-glycan synthesis genes that were subjected to agarose gel electrophoresis. 
The negative (-) control reaction mixture lacked the template cDNA. According to the intensity of 
PCR bands under the same condition, these genes were divided into highly expressed (++), low 
expressed (+) and not amplified (-).  
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4 DISCUSSION  
From insemination to fertilization, spermatozoa are protected by their glycocalyx against 
female cellular (macrophages, neutrophils) and humoral (complements, antibodies) immunity 
which principally could be triggered by spermatozoa as antigens [139, 140]. In addition to 
resisting female immunity, every single sperm carries a unique glycocalyx, due to several 
post-meiotic modifications during the transition from the testis to the epididymis and then by 
secretions of the accessory glands, denoting a sperm’s individuality. This individuality is 
postulated to be a selection characteristic in the female reproductive tract [7, 141]. In close 
proximity to the egg, capacitation induces the release of glycoproteins such as DEFB126 from 
the sperm surface. This capacitation-mediated release of these immunosuppressive 
glycoproteins from the sperm surface exposes underlying moieties which are necessary for 
sperm-egg binding [16, 141, 142].  
Following an inter-species insemination sperm trigger the production of antibodies in the 
female genital tract directed against non-self glycans, pointing to the species-specific 
characteristic of the sperm glycocalyx. In this regard, sialic acid types play an important role 
in inter-species incompatibility. Humans unlike other mammals are genetically unable to the 
synthesis of Neu5Gc and therefore are equipped with antibodies raised against Neu5Gc [143-
145].  
Two controversial findings were reported about the role of glycan moieties in the 
attachment of sperm to the zona pellucida. On one hand, studies based on a transgenic mouse 
model and MS analysis of ZP3 underestimated the importance of O-glycans in the zona 
pellucida [146, 147]. Instead, an N-terminal amino acid sequence of ZP2 was proposed to be 
necessary in the sperm-zona pellucida binding site [148]. On the other hand, many studies 
propose an essential role for glycans in fertilization particularly in mediating the specific 
interaction between spermatozoa and the zona pellucida of the egg [7, 49]. Binding of 
spermatozoa to the zona pellucida is thereby strongly induced by terminal Neu5Ac residues of 
SLex oligosaccharides on the surface of the zona pellucida. In addition, successful interaction 
of both gametes requires previous desialylation of the spermatozoal surface (Figure 35) [16]. 
For this purpose, spermatozoa are equipped with sialidases [16, 149-151]. Under normal 
conditions, neuraminidases are only activated in the female reproductive tract as a 
consequence of capacitation and/or the acrosome reaction [16, 149-151]. Two activated 
neuraminidases (NEU1, NEU3) on sperm mediate the removal of sialic acid moieties during 
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capacitation [16]. Different localization of detected neuraminidases (i.e. NEU1 in the oviduct, 
NEU3 in the oviduct and the uterus) may refer to a ligand-specific desialylation function of 
neuraminidases on glycoproteins and gangliosides, however, little detail is known [16]. 
According to a study by Ma et al. on the capacitation of sperm under a mimicry condition (in 
vitro), sialidase activity was abated in the presence of protease inhibitors. Thus, the release 
and activation of sperm sialidases during capacitation seems to be protease-dependent [16]. 
The treatment of sperm with a neuraminidase inhibitor (DANA) during the in vitro 
capacitation attenuated the phosphorylation of ERK and tyrosine, indicating a putative 
involvement of downstream signaling pathways (e.g. MAPK/ERK) in the function of 
neuraminidases [16]. Defects in the detachment of sialic acids from the surface of sperm play 
a negative role in sperm-zona pellucida interaction. For instance, the presence of a 
neuraminidase inhibitor (DANA) decreases the rate of in vitro fertilization, and the lack or 
lower expression level of neuraminidases are found in idiopathic infertile males. These 
findings emphasize the vital importance of a timely activation of sperm neuraminidases for 
fertilization [16]. In this study, the active role of neuraminidases in sperm hyposialylation is 
further confirmed by the observation of a higher level of sialic acid loss in the presence of 
neuraminidase (Figure 23). A process that was counteracted using a neuraminidase inhibitor 
(Figure 24). The glycocalyx on the spermatozoal surface undergoes massive redecoration 
after capacitation [16] and the acrosome reaction (Figure 35). Premature release of 
neuraminidases prior to ejaculation is usually avoided as untimely desialylation could result in 
elimination of spermatozoa by phagocytic cells [152]. In pathophysiological conditions such 
as bacterial epididymitis, considerable premature exocytosis of the acrosome has been 
observed in vivo and in vitro, which contributes substantially to the loss of fertilizing capacity 
as shown by subsequent in vitro fertilization (IVF) experiments in mouse [24].  
This prompted us to examine if undue acrosome reactions could affect the sialome of 
epididymal spermatozoa and surrounding epithelial cells. To study this, we used an 
established acute mouse bacterial epididymitis model and ejaculates of men with a recent 
history of the disease. 
Induction of the acrosome reaction causes sperm hyposialylation (Figure 21). UPEC also 
induces the acrosome reaction (Figure 22) and loss of sialic acids (Figure 23). Similarly, in 
murine epididymitis as well as in in vitro treated human spermatozoa, UPEC caused a 
premature acrosome reaction leading to a significant desialylation of spermatozoa as well as 
adjacent epithelial cells (illustrated in Figure 35). Surprisingly, the investigated desialylation 
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was much more pronounced in epididymitis patients, whose samples were collected 14 days 
after antibiotic therapy, than in mouse sperm (Figure 26). In patients the sperm 
hyposialylation coincided with undue acrosome reactions (Figure 25). The desialylation could 
be efficiently blocked with a neuraminidase inhibitor (DANA) in vitro (Figure 24), indicating 
that the loss of sialic acid residues is particularly a consequence of endogenous 
neuraminidases along with activation of the acrosome reaction (Figure 35). Hence, regarding 
the lower amount of Neu5Ac in UPEC treated sperm (+) compared to DANA+UPEC treated 
conditions (Figure 24), a release of sialic acid could be proposed due to activation of sperm 
neuraminidases during UPEC infection.   
A limitation in the analysis of human samples in this study is the relatively small number 
of semen samples from patients/controls suitable for glycoanalysis due to the need to clean 
ejaculates by the swim-up method. Since semen samples of patients with acute epididymitis 
are usually characterized by a largely reduced semen quality and leukocytospermia, the swim-
up technique was necessary to select the viable and motile sperm, thereby removing 
contaminating non-sperm cells (e.g. leukocytes), and thus, to avoid bias between patient and 
control samples. 
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Figure 35. Summary and working model. Blue box; In the female reproductive tract 
capacitation/acrosome reaction leads to a proteolytic activation and release of neuraminidases, 
resulting in a desialylation of spermatozoa required for sperm/egg interaction. Red box; UPEC 
induced acrosome reaction triggers a premature desialylation of spermatozoa and the release of sialic 
acid residues from adjacent cells in the male reproductive tract. Consequently, pathological 
hyposialylation may negatively influence the protection of host cells against phagocytosis and 
complement system. Green box; In vitro UPEC induced hyposialylation of spermatozoa could be 
counteracted using neuraminidase inhibitors [28]. (Copyright © 2016, by the American Society for 
Biochemistry and Molecular Biology) 
 
Sialic acids play multifactorial, mainly defensive, roles in the host response to infection. 
Thus, premature activation of sperm neuraminidases during epididymitis may endanger sperm 
via modulation of the immune response due to the lack of immune suppression by sialic acids 
after infection. However, the putative underlying immune mechanisms still need to be 
comprehensively addressed. 
Sialic acids in host-pathogen interactions mediate an anti-bacterial function through 
electrostatic repulsion characteristic of negative charged sialic acids on the surface of cells 
[153]. In this regard, the UPEC infection-associated desialylation of sperm may impair this 
defense barrier of the male gamete against pathogens. In contrast to the defensive role of 
sialylated glycans, some glycoconjugates on the host surface are used as receptors for a 
variety of pathogens [77, 89]. For instance, glycosylated mucus secretions are involved in 
penetration of some pathogens into the cell membrane of the host [154-156]. The attachment 
of pathogenic E. coli to glycoconjugates of human cells are mediated by lectin-like adhesins 
on FimH [157, 158]. Due to the desialylation and the resulting loss of negatively charged 
sialic acid residues, type-1 fimbriae like FimH may better reach potential binding partners 
such as Manα1-3Man or Manα1-3Manβ1-4GlcNAc [159]. Therefore, an altered and 
hyposialylated glycocalyx may predispose sperm as a potential target for pathogens such as 
UPEC. In contrast, a sialic acid dependent UPEC binding to epithelial cells was described 
[160]. Accordingly, the adhesion of UPEC to epididymal epithelial cells would be inhibited 
by epithelial desialylation. 
4.1 Possible effects of hyposialylation of sperm on the immune response  
Innate and adaptive immune responses are to a large extent modulated by the contribution 
of sialylated carbohydrates. Innate immune reactions (e.g. complement reaction) is suppressed 
by sialylated moieties present on the cell surface. Complement C1q initiates the classical 
complement pathway, resulting in phagocytic removal of targeted cells [161, 162]. Terminal 
                                                                                                                               DISCUSSION 
 
73 
 
sugar residues are decisive for attachment of C1q to their receptor structures [163]. For 
instance, microglia (as the resident macrophages of the central nervous system), which are 
involved in neuritis, require the binding of C1q to the complement receptor 3, a reaction 
which occurs only if the neuronal glycocalyx is desialylated [164]. This reflects the 
preventive effect of sialic acids on complement opsonization and microglial/macrophage 
phagocytosis [165, 166]. 
Massive release of sialic acid residues from the cell surface of epididymal epithelial cells 
and spermatozoa may contribute to the observed tissue damage in epididymitis (Figure 35). 
This view is supported by the fact that bacterial LPS triggers complement activation and that 
hyposialylation promotes the perforation of host cell membranes by the membrane attack 
complex counteracting a protective mechanism conveyed by complement factor H [144]. In 
this regard, complement factor H exhibits sialic acid specific binding domains, which are 
necessary for an efficient cell surface-binding [145]. As binding of sialic acids to factor H 
perturbs activation of complements, the alternative pathway of complement activation is also 
triggered in the absence of sialic acids [24]. Factor H on cell membranes is essential to 
remove activated complement factor 3b from cellular surfaces to prevent perforation of host 
cell membranes and limit tissue damage. As recently shown, complement factor H is an 
important component of seminal plasma as it protects spermatozoa against such a complement 
attack in the female reproductive tract [146]. Thus, hyposialylation of spermatozoa and other 
epididymal host cells may result in a deficit of sialic acid-dependent factor H binding and 
thus, less protection against the activated complement system. It seems that factor H 
attachment to surface sialic acids may play an important role in sperm survival which could 
be impaired by sialic acid loss caused by UPEC epididymitis. 
 Inflammation substantially alters the decoration of oligosaccharides in acute phase 
proteins such as pentraxin-related protein 3 (PTX3) [167, 168]. In UPEC-associated 
epididymitis, higher levels of proinflammatory cytokines (such as IL1, IL6, and TNF-α) are 
present [126]. Innate immune cells and several non-immune cell types secrete PTX3, a long 
pentraxin glycoprotein in the inflammatory response to TNF-α and IL-1ß [169-172]. The 
affinity of PTX3 to C1q is increased after enzymatic cleavage of the sialic acids in the N-
glycosylation binding site of PTX3, suggesting that PTX3 modulates the activity of 
complements by binding to C1q [163, 173-175]. 
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As a further point, CD52 modulates the classical complement pathway. The epididymis 
incorporates CD52 in the sperm plasma membrane [176, 177]. N- and O-glycans are 
associated with epididymal secreted CD52, which are different to those from lymphocyte type 
CD52 [176, 177]. Highly sialylated N-glycans of CD52 (consisting of N-acetyllactosamine 
repeats) suppress complements by interacting with C1q [178-180]. 
Moreover, many sialylated and polysialylated glycoproteins are integrated into the plasma 
membrane of spermatozoa during epididymal transit [119, 181]. These glycoproteins inhibit 
inter alia in a sialic acid-dependent way the phagocytosis by leukocytes as seen in murine 
spermatozoa [152, 182]. In this regard, the substantial loss of sialic acid residues during 
epididymitis could prompt phagocytosis of spermatozoa during transit through the epididymis 
and/or the female reproductive tract, as already indicated [152, 183].  
The presence of leukocytes (mainly macrophages) is a frequent observation in the lumen 
of the epididymal duct of healthy men and rodents. Together with neutrophils and T cells their 
numbers increase strongly in infection as a consequence of immune cell infiltration during 
epididymitis [11, 126, 184, 185]. In addition, phagocytic cells in semen are able to engulf 
abnormal sperm. Sialoglycoproteins, which are secreted by the epididymis and are bound to 
the sperm surface, inhibit phagocytosis by macrophages [152, 186]. Taken together, the 
substantial sialic acid deficiency caused by UPEC infection may enhance sperm vulnerability 
to phagocytosis during transit through the epididymis and/or possibly in the female genital 
tract [139].  
The adaptive immune response is also modulated by sialic acids. The monocyte-derived 
dendritic cell surface is highly sialylated [187]. In vitro α2,6 desialylation of dendritic cells 
(DCs) enhances the phagocytic capacity of E. coli pathovars, followed by an increase in the 
expression level of MHC molecules and cytokines (such as IL-12, IL-6, IL-10, and TNF-α) 
through activation of NF-κB and other signaling pathways [188]. Moreover, an increased 
number of some subpopulations of DC (e.g. CD11c+ IL-23+ myeloid DC, CD123+ 
plasmacytoid DC) in chronic epididymitis can be modulated in the same manner using sialic 
acids [189]. Therefore, it appears likely that soluble neuraminidase may also detach sialic acid 
residues from the cell surface of luminal immune cells in the epididymis during infection.  
Sialic acids in the form of polySia play a shielding role against neutrophils, which are 
major attacking immune cells to sperm following insemination. Neutrophils form a NET 
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(made of DNA, histones, anti-microbial peptides, proteins, and enzymes) to entrap foreigners 
(i.e. pathogens, spermatozoa) [190-192]. To evade this trap, NET is cleaved by the DNase of 
semen [191, 192]. After enzymatic degradation of NET, released histones are cytotoxic [193]. 
However, available polySias in glycoconjugates (i.e. neural cell adhesion molecule (NCAM) 
and polysialylated polysialyltransferase ST8SiaII), which are incorporated into sperm and 
epididymosomes, abolish the cytotoxicity of nucleosomes in the female innate immunity [119, 
194].  
4.2 Activation of siglecs as a putative consequence of sperm desialylation 
A large number of siglecs expressed in leukocytes interact with their ligands through sialic 
acids, leading to an immune discrimination between self and non-self [153, 195, 196]. Siglecs 
modulate both innate and adaptive immune responses [153]. For instance, the siglec CD22 
acts as a key regulator of B-cells, and modulates B-cell signaling function by recognition of 
α2,6-linked sialic acids [197]. Thus, terminal sialic acids of leukocytes play an important role 
in counteracting excessive immune response via an interaction with siglecs in cis [198]. The 
majority of siglecs (e.g. siglec G/10) dampens cell signaling activation by employing a 
tyrosine domain in the cytoplasmic tail [153, 199, 200]. Siglec G/10 is located on B-cells, 
macrophages, and DC. As an example, the anti-inflammatory signaling of siglec G/10 is 
activated by the interaction with sialic acid residues on CD24 in cis [198]. During sepsis, 
generation of inflammatory cytokines such as IL-6 and TNF, in response to binding of 
pathogen-associated molecular patterns and/or damage-associated molecular patterns to toll-
like receptors, is known to be repressed by sialylated glycans of CD24-bound siglec G/10 
[198, 201]. Thus, this complex represses tissue damage-induced immune responses [199], 
similar to those seen in infected epididymis [8]. Some bacteria like Clostridium perfringens 
secrete microbial sialidases targeting the described sialic acid mediated CD24-siglec G/10 
complex. As a consequence, mice have an increased risk of septicemia, as previously shown 
[198, 202]. Sialidase treatment aggravates pathogenicity, and conversely, sialidase inhibitors 
suppress the inflammatory response and septic symptoms [198]. Moreover, in natural killer 
(NK) cells, siglec-7 plays an inhibitory role when these cells are covered by (Neu5Acα2-
8Neu5Ac)-containing glycans. Sialidase treatment of NK cells enhances cytotoxicity in highly 
sialylated tissues [203-206]. In addition, sialic acid mediated functions of siglecs in sepsis 
were observed not only in white blood cells, but also in platelets. Sialic acid deficient platelets 
in infection are vulnerable to clearance by asialoglycoprotein receptors of hepatocytes, 
resulting in coagulopathy [207]. Thus, in epididymitis patients, activated endogenous 
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sialidases may act as an indirect virulence factor similar to microbial sialidases of Clostridium 
perfringens, Vibrio cholerae and Streptococcus pneumoniae [208]. 
4.3 Alterations of sperm glycocalyx in diagnosis and therapy of epididymitis patients 
Alterations in the glycosylation pattern of proteins are considered a diagnostic marker of 
some diseases [209, 210]. Based on our study, sperm desialylation during infectious 
epididymitis would be worth investigating as a diagnostic marker in subsequent male 
infertility. In addition, the putative consequences of antibiotic therapies on the status of sperm 
sialic acids should be further investigated. Sialidase inhibitor-based drugs (i.e. zanamivir, 
oseltamivir, peramivir, and laninamivir octanoate) are successfully used in the treatment of 
influenza [211]. Moreover, an administration of sialidase inhibitor in vivo decreased the 
damage of sepsis in a mouse model [212]. During UPEC infection of sperm in vitro, 
desialylation was inhibited using a neuraminidase inhibitor (Figures 24, 35). Thus, our study 
may also suggest a potential therapeutic application for neuraminidase inhibitors to preserve 
fertility of epididymitis patients.  
Putatively, a further level of intervention also could be upstream by blocking the 
proteolytic activation and release of neuraminidases using suitable protease inhibitors 
according to Ma et al. [79].  
4.4 Sperm glycans and their putative immunomodulatory roles during infection 
N-glycan analysis of human sperm revealed an association of three main classes of N-
glycans: oligomannose, complex, and hybrid (Figures 29, 31, 32). Intriguingly, detected 
oligomannose (carrying 3-9 Man in branches) and complex (forming bi-, tri-, tetraantennary 
and bisected biantennary structures, and bearing a core Fuc in the majority of them) types 
confirmed the MS profiling results of Pang et al. [105, 213].  
Previously analyzed MALDI-TOF MS data failed to identify varieties of sialylated N-
glycans in human spermatozoa [105]. In spite of these analyses, interestingly, obtained MS 
and MS/MS data (Figures 29-31) revealed ten sialylated compositions from complex and 
hybrid types of N-glycans. However, a comprehensive MS/MS is still required to further 
validate the association of these novel sialylated compositions with sperm, especially the 
hybrid types (Figure 31).  
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In addition to alterations in sialic acid moieties of spermatozoa following acrosome 
reaction (Figures 21, 35), an alteration in N-glycan compositions of sperm occurred following 
the induction of acrosome exocytosis (Figure 33). This massive redecoration in the sperm 
glycocalyx along with capacitation and the acrosome reaction may denote the loss of 
glycoconjugates (such as β-defensins and GPI-anchored proteins) together with the 
realignment of glycosylated structures (e.g. gangliosides) and glycan-altering enzymes (such 
as PH20) [7]. 
Clark et al. characterized sialylated bisecting biantennary compositions in sperm and the 
zona pellucida, hampering immune attacks of NK cells [214]. Additionally, these 
glycostructures are also applied in tumor cells, HIV, and Helicobacter pylori to mislead 
immune defense. During development, this bisecting biantennary structure is also present in 
α-fetoprotein found in the yolk sac and fetal liver [214] According to the hypothesis of the 
“eutherian fetoembryonic defense system”, this bisecting biantennary composition and other 
glycoproteins such as glycodelins present in the seminal plasma and amniotic fluid play an 
immunosuppressive role for gametes and developing embryos in the female reproductive tract 
[214]. In our study similar bisected biantennary compositions were identified in association 
with the glycocalyx of human spermatozoa. However, these bisected biantennary 
compositions were non-sialylated (Figure 32). 
The contribution of Fuc to the structure of Lewisx (either sialylated or non-sialylated 
types) and Lewisy was largely identified in complex structures of the human sperm N-
glycome (Figures 31, 32). This finding is consistent with MS analysis of Pang et al., who also 
demonstrated the localization of Lewisy to the acrosome [105]. Regarding the outlined roles of 
Lewisx and Lewisy in tolerance to host adaptive immune reactions, these motifs attenuate 
antigen-driven responses upon some pathogens (e.g. Helicobacter pylori, Schistosoma as 
parasitic helminths), and HIV-infected T cells [215-219]. In non-pathogenic variants of 
Helicobacter pylori, the Lewisx and Lewisy in LPS structures interact with DC through 
dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), 
and consequently, modulate the balance of Th1-Th2 [216]. A higher contribution of Lewisx 
compositions to the antennae of glycans enhances the affinity of glycans to DC-SIGN [220]. 
Conversely, the pathogenic variants of Helicobacter pylori that are devoid of Lewis 
compositions trigger an immense immune response [215]. Moreover, DC-SIGN strongly 
attaches to oligomannose structures [220, 221]. Therefore, the presence of several N-glycan 
compositions carrying high mannose, Lewisx, and Lewisy (Figure 32) together with sialylated 
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N-glycans in the sperm glycocalyx (Figure 31) may provide an immune privileged 
environment for sperm to suppress the immune response. Consequently, sperm can survive in 
the male and female reproductive organs, which are equipped with a physiological defense 
mechanism to abolish sexually transmitted pathogens and impaired spermatozoa [105, 213]. 
The detection of SLex in our study (Figure 31), however, is in contrast with the MS findings 
of Pang et al. that suggested the absence of SLex in the structure of N- and O-glycans of 
human seminal plasma [213]. Nevertheless, they did show, similar to our MS data in sperm, 
the substantial presence of Lewisx and Lewisy in seminal plasma [213].  
In addition to the structural analysis of the sperm and seminal plasma glycocalyx [213, 
222], future studies should address the putative correlation of UPEC infections and possible 
N-glycan alterations in sialylated and non-sialylated compositions, especially in the functional 
Lewis structures together with their immunomodulatory functions during epididymitis.  
Besides N-glycans, Lewisx and Lewisy compositions occur in O-glycans (e.g. mucins) of 
seminal plasma [223]. O-glycans were specifically detected in the acrosome of spermatid and 
spermatozoa (Figure 12) [224]. Functional core 1 and 2 structures of O-glycans, bearing sialic 
acid and/or Fuc in antennae (e.g. Lewisy), are present in the male reproductive tract on CD52. 
In addition, in infertile women, these O-glycan cores are also found in antisperm antibodies 
(i.e. sperm mobilizing and agglutinating antibodies) directed against CD52  [176, 177, 225].  
DEFB126 (as a sialoglycoprotein) plays an important protective role and enables sperm to 
resist female immune attacks [7, 113]. The presence of sialic acids in DEFB126 is known to 
be essential for the migration of sperm through the cervical mucus since the enzymatic 
desialylation of DEFB126 from spermatozoa in vitro diminishes successful transit in the 
cervical mucus [116]. Moreover, a deletion in DEFB126 abates the association of sperm 
coated O-glycans, leading to male subfertility, which is characterized by a defective 
competence of sperm to traverse the cervical mucus [226]. Detachment of DEFB126 from 
sperm causes a substantial increase against sperm immunogenic proteins in the immune 
response, including a remarkable elevation in affinity to antisperm antibodies (ADAM30, 
PH20) in the absence of DEFB126 or its sialic acid moieties [142]. Furthermore, DEFB126 
contributes to a temporary binding of sperm to epithelial cells of the oviduct, preserving the 
competent spermatozoa for subsequent fertilization [227]. However, around the time of 
ovulation and as a consequence of capacitation, DEFB126 is released from the sperm surface 
and the sperm-epithelium attachment dissociates [227, 228]. Additionally, this essential step, 
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which arises prior to the progress of sperm towards the egg, is impaired after neuraminidase 
treatment, denoting the functional role of sialic acids in DEFB126 [227]. However, a study of 
an array of twelve epididymal β-defensins in a LPS-caused epididymitis animal model 
demonstrated that the expression levels of these β-defensins are mainly attenuated, and the 
reduced expression of SPAG11E (as a caput secreted β-defensin) causes a motility failure of 
sperm [229]. Nevertheless, alterations of β-defensins against UPEC infection in the male 
reproductive tract are largely unknown. 
The initiating enzymes for synthesis of O-glycans show a different expression pattern in 
the epididymis (Figure 34). According to the study of Pang et al. only core 1 and core 2 are 
associated with seminal plasma and they are capped with sialic acid and/or Fuc [213]. 
Infertility, azoospermia, sperm malfunction, and malformation were reported along with the 
deletion of GalNAc-T3 as an initiating enzyme in the synthesis of O-glycans [230]. By 
contrast, normal spermatogenesis and fertility were indicated in GAL transferase 1 deficient 
mice whose core 2 was abrogated [231]. Moreover, other studies also provided no concrete 
evidence of sperm impairment following the deletion of O-glycan transferases in core 1 and 2 
mucins as well as in O-fucosylated glycans [65, 232].  
On the other hand, a deletion in a complex N-glycan synthesis gene (Mgat 1) coincides 
with a defect in spermatogenesis and apoptosis in spermatogenic cells [65] with 
multinucleated cells (MNC), instead of spermatozoa, visible in the lumen of the testis and 
occasionally in the epididymis [65]. The MNC appear alongside a disruption in the 
differentiation of spermatid into sperm [65]. MNC formation occurs as a consequence of the 
absence of complex N-glycan structures in gangliosides, which are sialylated 
glycosphingolipids, in Sertoli and germ cells, thereby causing a failure in the connection of 
spermatids to supporting cells [233-235]. In addition to gangliosides, complex N-glycans of 
cell adhesion molecules are involved in the attachment of spermatogonia to Sertoli cells, and 
their deficiency leads to MNC formation in the testis, and thus to male sterility [236-238]. 
Every spermatogenic cell contains various N-glycan types. For instance, in spermatocytes 
higher levels of oligomannose compared to complex N-glycans are present due to the 
inhibition of the synthesis of complex N-glycans by means of a specific upregulation of a 
Mgat1 inhibitor (i.e. GlcNAcT-I inhibitory protein (GnT1IP)) [239].  
In comparison to N-glycans, the essential effects of O-glycans in spermatogenesis and 
sperm functions appear underestimated. To alleviate this gap in knowledge, other O-glycan 
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types including other putative mucin cores (i.e. core 3-8) and O-mannosyl glycans need to be 
investigated.  
4.5 Massive alteration of sperm glycocalyx caused by UPEC infection 
In conclusion, the present study shows that UPEC-induced epididymitis is associated with 
the massive alteration in the glycocalyx of sperm and surrounding epithelial cells in the 
epididymis (Figure 35). Intriguingly, UPEC infection causes hyposialylation in mouse 
epididymal spermatozoa and epithelial cells as well as in ejaculated spermatozoa of men with 
past history of epididymitis. Likely this happens mechanistically through activation of 
endogenous sialidases. Hyposialylation has the potential to negatively impact on course and 
magnitude of infection in patients suffering from UPEC elicited epididymitis providing a 
possible explanation for the characteristic long-term impairment of fertility associated with 
this pathovar [53, 95]. However, the precise consequences of the examined hyposialylation 
and the potential of sialidase inhibitors as therapeutic agent during UPEC infection need to be 
further investigated. Moreover, the current study demonstrates a massive redistribution in N-
glycans (Figure 33) of human sperm as a consequence of the acrosome reaction, the 
exocytotic process which occurs untimely during UPEC infection (Figure 35). In spite of the 
mentioned papers, a better understanding is still needed in the comparative glycome analysis 
of human and mouse epididymal epithelial cells and spermatozoa to better judge how well the 
animal model reflects the situation in men. Furthermore, since O-glycans are expressed in the 
epididymis (Figure 34) and they contribute to sperm-associated glycoproteins (e.g. DEFB126) 
in protection against the immune response in the female genital tract [7], a comprehensive 
analysis of putative O-glycan alterations during UPEC infection in men and mice is 
warranted. Taken together, UPEC substantially manipulate the sophisticated decoration of the 
glycocalyx in sperm and epididymal epithelial cells, which predominately includes the 
remodeling of the sialome. Accordingly, these UPEC-caused alterations of the sperm 
glycocalyx may be implicated in male fecundity as sperm become vulnerable to the 
immunorecognition in the female reproductive tract. 
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5 SUMMARY 
In mammals, glycoconjugates (e.g. O-glycans, three major classes of N-glycans) coat the 
surface of sperm. Terminal sialic acid residues and/or fucose act immunosuppressive and 
facilitate the survival in the female reproductive organs. Urinary tract infections caused by 
uropathogenic Escherichia coli (UPEC) pathovars belong to the most frequent infections in 
human. In men, pathogens can also spread to the genital tract via the continuous ductal system 
eliciting bacterial prostatitis and/or epididymo-orchitis. Antibiotic treatment usually clears 
pathogens in acute epididymitis, however, fertility of patients can be permanently impaired. 
Since premature acrosome reaction was observed in an UPEC epididymitis mouse model and 
sialidases on the sperm surface are considered to be activated via proteases of the acrosome, 
we aimed to investigate whether alterations of the sialome of epididymal spermatozoa and 
surrounding epithelial cells occur during UPEC infection. We found a massive redecoration of 
sperm N-glycans, especially hyposialylation, along with an acrosome reaction induced in 
vitro. In UPEC elicited acute epididymitis in mouse, a substantial loss of N-acetylneuraminic 
acid (Neu5Ac) residues was detected in epididymal spermatozoa and epithelial cells using 
combined laser microdissection/HPLC-ESI-MS analysis. Lectin staining suggested that 
infection reduced substantially α2,6-linked Neu5AC in mouse epididymis and sperm. In 
support, a substantial reduction of sialic acid residues bound to the surface of spermatozoa 
was documented in men with a recent history of E. coli associated epididymitis concurrent 
with premature acrosome reaction. In vitro, such an UPEC induced Neu5Ac release from 
human spermatozoa was effectively counteracted by a sialidase inhibitor. These findings 
strongly suggest a substantial remodeling of the glycocalyx of spermatozoa and epididymal 
epithelial cells by endogenous sialidases after premature acrosome reaction during acute 
epididymitis.  
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6 ZUSAMMENFASSUNG 
Bei Säugetieren sind Spermatozoen mit Glycokonjugaten (z. B. O-Glykane, drei 
Hauptklassen von N-Glykanen) dekoriert. Diese besitzen immunsuppressive Eigenschaften. 
Vor allem N-terminale Neuraminsäuren und/oder Fucose schützen die Spermien vor 
Immunangriffen in weiblichen Reproduktionstrakt. Durch uropathogene Escherichia coli 
(UPEC) hervorgerufene Harnwegsinfektionen gehören zu den häufigsten Infektionen des 
Menschen. Bei Männern können sich Krankheitserreger auch kanalikulär in den Genitaltrakt 
ausbreiten und eine bakterielle Prostatitis und/oder Epididymo-Orchitis hervorrufen. Eine 
Antibiotika-Behandlung eradiziert in der Regel die Krankheitserreger bei akuter Epididymitis, 
dennoch kann es zu einer dauerhaften Beeinträchtigung der Fruchtbarkeit der betroffenen 
Männer kommen. Eine massive Redekoration der N-Glycane auf Spermien, insbesondere ein 
starker Verlust an Sialinsäure (Hyposialylation), ist mit einer experimenell-induzierten 
acrosomalen Reaktion assoziiert. Da bereits eine vorzeitige acrosomale Reaktion in einem 
UPEC-induzierten Epididymitis-Mausmodell beobachtet wurde, und zudem Sialidasen auf der 
Spermienoberfläche vermutlich durch Proteasen des Akrosoms aktiviert werden können, war 
es das Ziel dieser Arbeit zu untersuchen, ob Veränderungen des Sialoms im Nebenhoden bei 
der Epididymitis auftreten. Ein substantieller Verlust an N-Acetylneuraminsäure (Neu5Ac)-
Resten wurde in epididymalen Spermatozoen und Epithelzellen der UPEC-induzierten akuten 
Epididymitis der Maus mittels kombinierter Laser-Mikrodissektion/HPLC-ESI-MS-Analyse 
nachgewiesen. Lektin-Färbungen lassen vermuten, dass die Infektion zu einer deutlichen 
Verminderung der α2,6-verknüpften Neu5Ac im Nebenhoden und in den luminalen Spermien 
führt. Unterstützend wurde bei Männern mit einer kürzlich diagnostizierten E. coli-
assoziierten Epididymitis eine deutliche Verringerung der gebundenen Sialinsäurereste an der 
Oberfläche der Spermien zusammen mit einer vorzeitigen acrosomalen Reaktion 
dokumentiert. Die UPEC-induzierte Neu5Ac-Freisetzung aus menschlichen Spermien konnte 
in vitro wirksam durch einen Sialidase-Inhibitor gehemmt werden. Diese Ergebnisse legen 
eine wesentliche Umgestaltung der Glykokalyx von Spermatozoen und epididymalen  
Epithelzellen durch endogene Sialidasen nach vorzeitiger Akrosomenreaktion während der 
akuten Epididymitis nahe. 
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